REFERENCES
- Barrett A J. Cystatin, the egg white inhibitor of cysteine proteinases. Methods Enzymol. 1981; 80: 771–8
- Bostom A G, Dworkin L D. Cystatin C measurement: Improved detection of mild decrements in glomerular filtration rate versus creatinine-based estimates?. Am J Kidney Dis. 2000; 36: 205–7. [PUBMED], [INFOTRIEVE]
- Deinum J, Derkx F H. Cystatin for estimation of glomerular filtration rate?. Lancet. 2000; 356: 1624–5. [PUBMED], [INFOTRIEVE]
- Risch L, Huber A R. Assessing the diagnostic accuracy of cystatin C as a marker of impaired glomerular filtration rate. Am J Kidney Dis. 2002; 39: 661–2. [PUBMED], [INFOTRIEVE]
- Bobek L A, Levine M J. Cystatins—inhibitors of cysteine proteinases. Crit Rev Oral Biol Med. 1992; 3: 307–32. [PUBMED], [INFOTRIEVE]
- Barrett A J. The cystatins: small protein inhibitors of cysteine proteinases. Prog Clin Biol Res. 1985; 180: 105–16. [PUBMED], [INFOTRIEVE]
- Chen J M, Dando P M, Rawlings N D, Brown M A, Young N E, Stevens R A, Hewitt E, Watts C, Barrett A J.. Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase. J Biol Chem. 1997; 272: 8090–8. [PUBMED], [INFOTRIEVE]
- Sen L C, Whitaker J R. Some properties of a ficin-papain inhibitor from avian egg white. Arch Biochem Biophys. 1973; 158: 623–32. [PUBMED], [INFOTRIEVE]
- Keilová H, Tomásek V. Effect of papain inhibitor from chicken egg white on cathepsin B1. Biochim Biophys Acta. 1974; 334: 179–86
- Barrett A J, Fritz H, Grubb A, Isemura S, Järvinen M, Katunuma N, Machleidt W, Müller-Esterl W, Sasaki M, Turk V.. Nomenclature and classification of the proteins homologous with the cysteine-proteinase inhibitor chicken cystatin. Biochem J. 1986; 236: 312, [PUBMED], [INFOTRIEVE]
- Barrett A J. The cystatins: A diverse superfamily of cysteine peptidase inhibitors. Biomed Biochim Acta. 1986; 45: 1363–74. [PUBMED], [INFOTRIEVE]
- Shaw P A, Cox J A, Barka T, Naito Y.. Cloning and sequencing of cDNA encoding a rat salivary cysteine proteinase inhibitor inducible by beta-adrenergic agonists. J Biol Chem. 1988; 236: 18133–37
- Rawlings N D, Barrett A J. Evolution of proteins of the cystatin superfamily. J Mol Evol. 1990; 30: 60–71. [PUBMED], [INFOTRIEVE]
- Dickinson D P. Salivary (sd-type) cystatins: Over one billion years in the making—but to what purpose?. Crit Rev Oral Biol Med. 2002; 13: 485–508. [PUBMED], [INFOTRIEVE]
- Brzin J, Kopitar M, Turk V, Machleidt W. Protein inhibitors of cysteine proteinases. Isolation and characterization of stefin, a cytosolic protein inhibitor of cysteine proteinases from human polymorphonuclear granulocytes. Hoppe Seyler's Z Physiol Chem. 1983; 364: 1475–80. [PUBMED], [INFOTRIEVE]
- Hsieh W T, Fong D, Sloane B F, Golembieski W, Smith D I. Mapping of the gene for human cysteine proteinase inhibitor stefin A, STF1, to chromosome 3cen-q21. Genomics. 1991; 9: 207–9. [PUBMED], [INFOTRIEVE]
- Takahashi H, Asano K, Kinouchi M, Ishida-Yamamoto A, Wuepper K D, Iizuka H.. Structure and transcriptional regulation of the human cystatin A gene. The 12-O-tetradecanoylphorbol-13-acetate (TPA) responsive element-2 site (−272 to −278) on cystatin A gene is critical for TPA-dependent regulation. J Biol Chem. 1998; 273: 17375–80. [PUBMED], [INFOTRIEVE]
- Turk V, Bode W. The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett. 1991; 285: 213–9. [PUBMED], [INFOTRIEVE]
- Björklund H V, Johansson T R, Rinne A. Rhabdovirus-induced apoptosis in a fish cell line is inhibited by a human endogenous acid cysteine proteinase inhibitor. J Virol. 1997; 71: 5658–62
- Bespalova I N, Pranzatelli M, Burmeister M. G to C transversion at a splice acceptor site causes exon skipping in the cystatin B gene. Mutat Res. 1997; 382: 67–74. [PUBMED], [INFOTRIEVE]
- Lalioti M D, Scott H S, Buresi C, Rossier C, Bottani A, Morris M A, Malafosse A, Antonarakis S E. Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy. Nature. 1997; 386: 847–51. [PUBMED], [INFOTRIEVE]
- Virtaneva K, D'Amato E, Miao J, Koskiniemi M, Norio R, Avanzini G, Franceschetti S, Michelucci R, Tassinari C A, Omer S, Pennacchio L A, Myers R M, Dieguez-Lucena J L, Krahe R, de la, Chapelle A, Lehesjoki A E. Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1. Nat Genet. 1997; 15: 393–6. [PUBMED], [INFOTRIEVE]
- Lehesjoki A E. Molecular background of progressive myoclonus epilepsy. EMBO J. 2003; 22: 3473–8. [PUBMED], [INFOTRIEVE]
- Freije J P, Abrahamson M, Ólafsson I, Velasco G, Grubb A, Lopez-Otin C.. Structure and expression of the gene encoding cystatin D, a novel human cysteine proteinase inhibitor. J Biol Chem. 1991; 266: 20538–43. [PUBMED], [INFOTRIEVE]
- Ni J, Abrahamson M, Zhang M, Fernandez M A, Grubb A, Su J, Yu G L, Li Y, Parmelee D, Xing L, Coleman T A, Gentz S, Thotakura R, Nguyen N, Hesselberg M, Gentz R. Cystatin E is a novel human cysteine proteinase inhibitor with structural resemblance to family 2 cystatins. J Biol Chem. 1997; 272: 10853–8. [PUBMED], [INFOTRIEVE]
- Ni J, Fernandez M A, Danielsson L, Chillakuru R A, Zhang J, Grubb A, Su J, Gentz R, Abrahamson M. Cystatin F is a glycosylated human low molecular weight cysteine proteinase inhibitor. J Biol Chem. 1998; 273: 24797–804. [PUBMED], [INFOTRIEVE]
- Tu G F, Aldred A R, Southwell B R, Schreiber G. Strong conservation of the expression of cystatin C gene in choroid plexus. Am J Physiol. 1992; 263: R195–200. [PUBMED], [INFOTRIEVE]
- Yamashita M, Konagaya S. Molecular cloning and gene expression of chum salmon cystatin. J Biochem (Tokyo). 1996; 120: 483–7
- Esnard F, Esnard A, Faucher D, Capony J P, Derancourt J, Brillard M, Gauthier F. Rat cystatin C: The complete amino acid sequence reveals a site for N-glycosylation. Biol Chem Hoppe Seyler. 1990; 371: 161–6. [PUBMED], [INFOTRIEVE]
- Isemura S, Saitoh E, Sanada K, Minakata K. Identification of full-sized forms of salivary (S-type) cystatins (Cystatin SN, cystatin SA, cystatin S, and two phosphorylated forms of cystatin S) in human whole saliva and determination of phosphorylation sites of cystatin S. J Biochem (Tokyo). 1991; 110: 648–54
- Hiltke T R, Lee T C, Bobek L A. Structure/function analysis of human cystatin SN and comparison of the cysteine proteinase inhibitory profiles of human cystatins C and SN. J Dent Res. 1999; 78: 1401–9. [PUBMED], [INFOTRIEVE]
- Freije J P, Balbin M, Abrahamson M, Velasco G, Dalboge H, Grubb A, Lopez-Otin C. Human cystatin D. cDNA cloning, characterization of the Escherichia coli expressed inhibitor, and identification of the native protein in saliva. J Biol Chem. 1993; 268: 15737–44. [PUBMED], [INFOTRIEVE]
- Halfon S, Ford J, Foster J, Dowling L, Lucian L, Sterling M, Xu Y, Weiss M, Ikeda M, Liggett D, Helms A, Caux C, Lebecque S, Hannum C, Menon S, McClanahan T, Gorman D, Zurawski G. Leukocystatin, a new Class II cystatin expressed selectively by hematopoietic cells. J Biol Chem. 1998; 273: 16400–8. [PUBMED], [INFOTRIEVE]
- Hashimoto S I, Suzuki T, Nagai S, Yamashita T, Toyoda N, Matsushima K. Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression. Blood. 2000; 96: 2206–14. [PUBMED], [INFOTRIEVE]
- Nathanson C M, Wasselius J, Wallin H, Abrahamson M. Regulated expression and intracellular localization of cystatin F in human U937 cells. Eur J Biochem. 2002; 269: 5502–11. [PUBMED], [INFOTRIEVE]
- Abrahamson M, Grubb A, Ólafsson I, Lundwall A. Molecular cloning and sequence analysis of cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin C. FEBS Lett. 1987; 216: 229–33. [PUBMED], [INFOTRIEVE]
- Sotiropoulou G, Anisowicz A, Sager R.. Identification, cloning, and characterization of cystatin M, a novel cysteine proteinase inhibitor, down-regulated in breast cancer. J Biol Chem. 1997; 272: 903–10. [PUBMED], [INFOTRIEVE]
- Stenman G, Astrom A K, Roijer E, Sotiropoulou G, Zhang M, Sager R. Assignment of a novel cysteine proteinase inhibitor (CST6) to 11q13 by fluorescence in situ hybridization. Cytogenet Cell Genet. 1997; 76: 45–6. [PUBMED], [INFOTRIEVE]
- Schnittger S, Gopal Rao VVN, Abrahamson M, Hansmann I. Cystatin C (CST3), the candidate gene for hereditary cystatin C amyloid angiopathy (HCCAA), and other members of the cystatin gene family are clustered on chromosome 20p11.2. Genomics. 1993; 16: 50–5. [PUBMED], [INFOTRIEVE]
- Zeeuwen P L, Van, Vlijmen-Willems I M, Jansen B J, Sotiropoulou G, Curfs J H, Meis J F, Janssen J J, Van, Ruissen F, Schalkwijk J. Cystatin M/E expression is restricted to differentiated epidermal keratinocytes and sweat glands: A new skin-specific proteinase inhibitor that is a target for cross-linking by transglutaminase. J Invest Dermatol. 2001; 116: 693–701. [PUBMED], [INFOTRIEVE]
- Müller-Esterl W, Fritz H, Kellermann J, Lottspeich F, Machleidt W, Turk V. Genealogy of mammalian cysteine proteinase inhibitors. Common evolutionary origin of stefins, cystatins and kininogens. FEBS Lett. 1985; 191: 221–6
- Kellermann J, Haupt H, Auerswald E A, Muller-Ester W. The arrangement of disulfide loops in human alpha 2-HS glycoprotein. Similarity to the disulfide bridge structures of cystatins and kininogens. J Biol Chem. 1989; 264: 14121–8. [PUBMED], [INFOTRIEVE]
- Deneke B, Gräber S, Schäfer C, Helss A, Wöltje M, Jahnen-Dechent W. Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A. Biochem J. 2003; 376: 135–45
- James L A, Ogilvie D J, Yamakawa K, Nakamura Y, Stirling C J, Anand R.. Walking, cloning, and mapping with YACs in 3q27: Localization of five ESTs including three members of the cystatin gene family and identification of CpG islands. Genomics. 1996; 32: 425–30. [PUBMED], [INFOTRIEVE]
- Winderickx J, Hemschoote K, de, Clercq N, Van, Dijck P, Peeters B, Rombauts W, Verhoeven G, Heyns W. Tissue-specific expression and androgen regulation of different genes encoding rat prostatic 22-kilodalton glycoproteins homologous to human and rat cystatin. Mol Endocrinol. 1990; 4: 657–67. [PUBMED], [INFOTRIEVE]
- Aumuller G, Arce E A, Heyns W, Vercaeren I, Dammshauser I, Seitz J. Immunocytochemical localization of seminal proteins in salivary and lacrimal glands of the rat. Cell Tissue Res. 1995; 280: 171–81. [PUBMED], [INFOTRIEVE]
- Cornwall G A, Orgebin-Crist M C, Hann S R. The CRES gene: A unique testis-regulated gene related to the cystatin family is highly restricted in its expression to the proximal region of the mouse epididymis. Mol Endocrinol. 1992; 6: 1653–64. [PUBMED], [INFOTRIEVE]
- Cornwall G A, Cameron A, Lindberg I, Hardy D M, Cormier N, Hsia N. The cystatin-related epididymal spermatogenic protein inhibits the serine protease prohormone convertase 2. Endocrinology. 2003; 144: 901–8. [PUBMED], [INFOTRIEVE]
- Shoemaker K, Holloway J L, Whitmore T E, Maurer M, Feldhaus A L. Molecular cloning, chromosome mapping and characterization of a testis-specific cystatin-like cDNA, cystatin T. Gene. 2000; 245: 103–8. [PUBMED], [INFOTRIEVE]
- Cornwall G A, Hsia N, Sutton H G.. Structure, alternative splicing and chromosomal localization of the cystatin-related epididymal spermatogenic gene. Biochem J. 1999; 340: 85–93. [PUBMED], [INFOTRIEVE]
- Yang Y, Cun S, Peng L, Xie X, Wei J, Yang W, Xu A. cDNA cloning, identification and characterization of a novel cystatin from the tentacle of Cyanea capillata. Biochimie. 2003; 85: 1033–9. [PUBMED], [INFOTRIEVE]
- Abrahamson M, Ritonja A, Brown M A, Grubb A, Machleidt W, Barrett A J. Identification of the probable inhibitory reactive sites of the cysteine proteinase inhibitors human cystatin C and chicken cystatin. J Biol Chem. 1987; 262: 9688–94. [PUBMED], [INFOTRIEVE]
- Björk I, Alriksson E, Ylinenjarvi K. Kinetics of binding of chicken cystatin to papain. Biochemistry. 1989; 28: 1568–73
- North M J, Mottram J C, Coombs G H. Cysteine proteinases of parasitic protozoa. Parasitology Today. 1990; 6: 270–5. [PUBMED], [INFOTRIEVE]
- Agarwala K L, Kawabata S, Takao T, Murata H, Shimonishi Y, Nishimura H, Iwanaga S. Activation peptide of human factor IX has oligosaccharides O-glycosidically linked to threonine residues at 159 and 169. Biochemistry. 1994; 33: 5167–71. [PUBMED], [INFOTRIEVE]
- Korant B D, Brizin J, Turk V.. Cystatin, a protein inhibitor of cysteine proteinases, alters viral protein clivages in infected human cells. Biochem Biophys Res Commun. 1985; 127: 1072–6. [PUBMED], [INFOTRIEVE]
- Aoki H, Akaike T, Abe K, Kuroda M, Arai S, Okamura R-I, Negi A, Maeda H. Antiviral effect of oryzacystatin, a proteinase inhibitor in rice, against Herpes Simplex virus type I in vitro and in vivo. Antimicrob Agents Chemother. 1995; 39: 846–9. [PUBMED], [INFOTRIEVE]
- Dickinson D P. Cysteine peptidases of mammals: Their biological roles and potential effects in the oral cavity and other tissues in health and disease. Crit Rev Oral Biol Med. 2002; 13: 238–75. [PUBMED], [INFOTRIEVE]
- Burnett D, Abrahamson M, Devalia J L, Sapsford R J, Davies R J, Buttle D J.. Synthesis and secretion of procathepsin B and cystatin C by human bronchial epithelial cells in vitro: Modulation of cathepsin B activity by neutrophil elastase. Arch Biochem Biophys. 1995; 317: 305–10. [PUBMED], [INFOTRIEVE]
- Popovic T, Cimerman N, Dolenc I, Ritonja A, Brzin J. Cathepsin L is capable of truncating cystatin C of 11 N-terminal amino acids. FEBS Lett. 1999; 455: 92–6. [PUBMED], [INFOTRIEVE]
- Tort J, Brindley P J, Knox D, Wolfe K H, Dalton J P.. Proteinases and associated genes of parasitic helminths. Adv Parasitol. 1999; 43: 161–266. [PUBMED], [INFOTRIEVE]
- Lamkin M S, Oppenheim F G. Structural features of salivary function. Crit Rev Oral Biol Med. 1993; 4: 251–9. [PUBMED], [INFOTRIEVE]
- Schinke T, Amendt C, Trindl A, Poschke O, Muller-Esterl W, Jahnen-Dechent W. The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J Biol Chem. 1996; 271: 20789–96. [PUBMED], [INFOTRIEVE]
- Afonso S, Romagnano L, Babiarz B. The expression and function of cystatin C and cathepsin B and cathepsin L during mouse embryo implantation and placentation. Development. 1997; 124: 3415–25. [PUBMED], [INFOTRIEVE]
- Clausen J. Proteins in normal cerebrospinal fluid not found in serum. Proc Soc Exp Biol Med. 1961; 107: 170–2. [PUBMED], [INFOTRIEVE]
- Butler E A, Flynn F V. The occurence of post-gamma protein in urine: A new abnormality. J Clin Pathol. 1961; 14: 172–8. [PUBMED], [INFOTRIEVE]
- MacPherson C FC, Cosgrove J BR. Immunochemical evidence for a gamma globulin peculiar to cerebrospinal fluid. Can J Biochem Physiol. 1961; 39: 1567–74
- Hochwald G M, Thorbecke G J. Use of an antiserum against cerebrospinal fluid in demonstration of trace proteins in biological fluids. Proc Soc Exp Biol Med. 1962; 109: 91–5. [PUBMED], [INFOTRIEVE]
- Laterre E C, Heremans J F, Carbonara A. Immunological comparison of some proteins found in cerebrospinal fluid, urine and extracts from brain and kidney. Clin Chim Acta. 1964; 10: 197–209. [PUBMED], [INFOTRIEVE]
- Manuel Y. Les proteines du liquid cephalorachidien. University of Lyon, LyonFrance 1965
- Cejka J, Fleischmann L E. Post-γ-globulin: Isolation and physicochemical characterization. Arch Biochem Biophys. 1973; 157: 168–76. [PUBMED], [INFOTRIEVE]
- Tonnelle C, Collé A, Fougereau M, Manuel Y. Partial amino acid sequence of two forms of human post-gamma-globulin. Biochem Biophys Res Commun. 1979; 86: 613–9. [PUBMED], [INFOTRIEVE]
- Poulik M D, Shinnick C S, Smithies O. Partial amino acid sequences of human and dog post-gamma globulins. Mol Immunol. 1981; 18: 569–72. [PUBMED], [INFOTRIEVE]
- Hochwald G M, Pepe A J, Thorbecke G J. Trace proteins in biological fluids. IV. Physicochemical properties and sites of formation of gamma-trace and beta-trace proteins. Proc Soc Exp Biol Med. 1967; 124: 961–6. [PUBMED], [INFOTRIEVE]
- Grubb A, Löfberg H. Human gamma-trace, a basic microprotein: Amino acid sequence and presence in the adenohypophysis. Proc Natl Acad Sci USA. 1982; 79: 3024–7. [PUBMED], [INFOTRIEVE]
- Turk V, Brzin J, Longer M, Ritonja A, Eropkin M, Borchart U, Machleidt W. Protein inhibitors of cysteine proteinases. III. Amino-acid sequence of cystatin from chicken egg white. Hoppe Seylers Z Physiol Chem. 1983; 364: 1487–96. [PUBMED], [INFOTRIEVE]
- Brzin J, Popovic T, Turk V, Borchart U, Machleidt W. Human cystatin, a new protein inhibitor of cysteine proteinases. Biochem Biophys Res Commun. 1984; 118: 103–9. [PUBMED], [INFOTRIEVE]
- Barrett A J, Davies M E, Grubb A. The place of human gamma-trace (cystatin C) amongst the cysteine proteinase inhibitors. Biochem Biophys Res Commun. 1984; 120: 631–6. [PUBMED], [INFOTRIEVE]
- Henskens Y M, Veerman E C, Nieuw Amerongen AV. Cystatins in health and disease. Biol Chem Hoppe Seyler. 1996; 377: 71–86. [PUBMED], [INFOTRIEVE]
- Dickinson D P, Zhao Y, Thiesse M, Siciliano M J. Direct mapping of seven genes encoding human type 2 cystatins to a single site located at 20p11.2. Genomics. 1994; 24: 172–5. [PUBMED], [INFOTRIEVE]
- Saitoh E, Isemura S, Sanada K, Ohnishi K. Characterization of two members (CST4 and CST5) of the cystatin gene family and molecular evolution of cystatin genes. Agents Actions Suppl. 1992; 38: 340–8. [PUBMED], [INFOTRIEVE]
- Dickinson D P, Thiesse M, Dempsey L D, Millar S J. Genomic cloning, physical mapping, and expression of human type 2 cystatin genes. Crit Rev Oral Biol Med. 1993; 4: 573–80. [PUBMED], [INFOTRIEVE]
- Thiesse M, Millar S J, Dickinson D P. The human type 2 cystatin gene family consists of eight to nine members, with at least seven genes clustered at a single locus on human chromosome 20. DNA Cell Biol. 1994; 13: 97–116. [PUBMED], [INFOTRIEVE]
- Saitoh E, Kim H S, Smithies O, Maeda N. Human cysteine-proteinase inhibitors: Nucleotide sequence analysis of three members of the cystatin gene family. Gene. 1987; 61: 329–38. [PUBMED], [INFOTRIEVE]
- Tohonen V, Osterlund C, Nordqvist K. Testatin: A cystatin-related gene expressed during early testis development. Proc Natl Acad Sci USA. 1998; 95: 14208–13. [PUBMED], [INFOTRIEVE]
- Eriksson A, Tohonen V, Wedell A, Nordqvist K. Isolation of the human testatin gene and analysis in patients with abnormal gonadal development. Mol Hum Reprod. 2002; 8: 8–15. [PUBMED], [INFOTRIEVE]
- Martineau J, Nordqvist K, Tilmann C, Lovell-Badge R, Capel B. Male-specific cell migration into the developing gonad. Curr Biol. 1997; 7: 958–68. [PUBMED], [INFOTRIEVE]
- Ólafsson I. The human cystatin C gene promoter: Functional analysis and identification of heterogeneous mRNA. Scand J Clin Lab Invest. 1995; 55: 597–607
- Möller C A, Lofberg H, Grubb A O, Olsson S O, Davies M E, Barrett A J. Distribution of cystatin C (gamma-trace), an inhibitor of lysosomal cysteine proteinases, in the anterior lobe of simian and human pituitary glands. Neuroendocrinology. 1985; 41: 400–4
- Kolar Z, Jarvinen M, Negrini R. Demonstration of proteinase inhibitors cystatin A, B and C in breast cancer and in cell lines MCF-7 and ZR-75–1. Neoplasma. 1989; 36: 185–9. [PUBMED], [INFOTRIEVE]
- Abrahamson M, Ólafsson I, Palsdottir A, Ulvsback M, Lundwall A, Jensson O, Grubb A.. Structure and expression of the human cystatin C gene. Biochem J. 1990; 268: 287–94. [PUBMED], [INFOTRIEVE]
- Corticchiato O, Cajot J F, Abrahamson M, Chan S J, Keppler D, Sordat B. Cystatin C and cathepsin B in human colon carcinoma: Expression by cell lines and matrix degradation. Int J Cancer. 1992; 52: 645–52. [PUBMED], [INFOTRIEVE]
- Sekine T, Poulik M D. Post-gamma globulin: Tissue distribution and physicochemical characteristics of dog post-gamma globulin. Clin Chim Acta. 1982; 120: 225–35. [PUBMED], [INFOTRIEVE]
- Tavera C, Prevot D, Girolami J P, Leung-Tack J, Collé A.. Tissue and biological fluid distribution of cysteine proteinases inhibitor: Rat cystatin C. Biol Chem Hoppe Seyler. 1990; 371(Suppl)187–92. [PUBMED], [INFOTRIEVE]
- Huh C, Nagle J W, Kozak C A, Abrahamson M, Karlsson S. Structural organization, expression and chromosomal mapping of the mouse cystatin-C-encoding gene (Cst3). Gene. 1995; 152: 221–6. [PUBMED], [INFOTRIEVE]
- Colella R, Johnson A, Bird J W. Steady-state cystatin mRNA levels in chicken tissues in response to estrogen. Biomed Biochim Acta. 1991; 50: 607–11. [PUBMED], [INFOTRIEVE]
- Dickinson D P, Thiesse M, Hicks M J. Expression of type 2 cystatin genes CST1–CST5 in adult human tissues and the developing submandibular gland. DNA Cell Biol. 2002; 21: 47–65. [PUBMED], [INFOTRIEVE]
- Solem M, Rawson C, Lindburg K, Barnes D. Transforming growth factor beta regulates cystatin C in serum-free mouse embryo (SFME) cells. Biochem Biophys Res Commun. 1990; 172: 945–51. [PUBMED], [INFOTRIEVE]
- Balbin M, Grubb A, Abrahamson M. An Ala/Thr variation in the coding region of the human cystatin C gene (CST3) detected as a SstII polymorphism. Hum Genet. 1993; 92: 206–7. [PUBMED], [INFOTRIEVE]
- Finckh U, von der, Kammer H, Velden J, Michel T, Andresen B, Deng A, Zhang J, Muller-Thomsen T, Zuchowski K, Menzer G, Mann U, Papassotiropoulos A, Heun R, Zurdel J, Holst F, Benussi L, Stoppe G, Reiss J, Miserez A R, Staehelin H B, Rebeck G W, Hyman B T, Binetti G, Hock C, Growdon J H, Nitsch R M. Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease. Arch Neurol. 2000; 57: 1579–83. [PUBMED], [INFOTRIEVE]
- Balbin M, Abrahamson M. SstII polymorphic sites in the promoter region of the human cystatin C gene. Hum Genet. 1991; 87: 751–2. [PUBMED], [INFOTRIEVE]
- Beyer K, Lao J I, Gomez M, Riutort N, Latorre P, Mate J L, Ariza A. Alzheimer's disease and the cystatin C gene polymorphism: An association study. Neurosci Lett. 2001; 315: 17–20. [PUBMED], [INFOTRIEVE]
- Olson J M, Goddard K A, Dudek D M. A second locus for very-late-onset Alzheimer disease: A genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region. Am J Hum Genet. 2002; 71: 154–61. [PUBMED], [INFOTRIEVE]
- Ghiso J, Jensson O, Frangione B. Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C). Proc Natl Acad Sci USA. 1986; 83: 2974–8. [PUBMED], [INFOTRIEVE]
- Lerner U H, Grubb A. Human cystatin C, a cysteine proteinase inhibitor, inhibits bone resorption in vitro stimulated by parathyroid hormone and parathyroid hormone-related peptide of malignancy. J Bone Miner Res. 1992; 7: 433–40. [PUBMED], [INFOTRIEVE]
- Lerner U H, Johansson L, Ranjso M, Rosenquist J B, Reinholt F P, Grubb A. Cystatin C, an inhibitor of bone resorption produced by osteoblasts. Acta Physiol Scand. 1997; 161: 81–92. [PUBMED], [INFOTRIEVE]
- Abrahamson M. Molecular basis for amyloidosis related to hereditary brain hemorrhage. Scand J Clin Lab Invest Suppl. 1996; 226: 47–56. [PUBMED], [INFOTRIEVE]
- Popovic T, Brzin J, Ritonja A, Turk V. Different forms of human cystatin C. Biol Chem Hoppe Seyler. 1990; 371: 575–80. [PUBMED], [INFOTRIEVE]
- Grubb A, Löfberg H. Human gamma-trace. Structure, function and clinical use of concentration measurements. Scand J Clin Lab Invest Suppl. 1985; 177: 7–13. [PUBMED], [INFOTRIEVE]
- Chapman H A, Jr.. Role of enzyme receptors and inhibitors in regulating proteolytic activities of macrophages. Ann N Y Acad Sci. 1991; 624: 87–96. [PUBMED], [INFOTRIEVE]
- Chapman H A, Jr, Reilly J J, Jr, Yee R, Grubb A. Identification of cystatin C, a cysteine proteinase inhibitor, as a major secretory product of human alveolar macrophages in vitro. Am Rev Respir Dis. 1990; 141: 698–705. [PUBMED], [INFOTRIEVE]
- Lignelid H, Collins V P, Jacobsson B. Cystatin C and transthyretin expression in normal and neoplastic tissues of the human brain and pituitary. Acta Neuropathol. 1997; 93: 494–500. [PUBMED], [INFOTRIEVE]
- Lignelid H, Jacobsson B. Cystatin C in the human pancreas and gut: An immunohistochemical study of normal and neoplastic tissues. Virchows Arch A Pathol Anat Histopathol. 1992; 421: 491–5. [PUBMED], [INFOTRIEVE]
- Newman D J. Cystatin C. Ann Clin Biochem. 2002; 39: 89–104. [PUBMED], [INFOTRIEVE]
- Abrahamson M, Barrett A J, Salvesen G, Grubb A. Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. J Biol Chem. 1986; 261: 11282–9. [PUBMED], [INFOTRIEVE]
- Bjarnadottir M, Grubb A, Ólafsson I.. Promoter-mediated, dexamethasone-induced increase in cystatin C production by HeLa cells. Scand J Clin Lab Invest. 1995; 55: 617–23. [PUBMED], [INFOTRIEVE]
- Solem M, Rawson C, Lindburg K, Barnes D. Transforming growth factor beta regulates cystatin C in serum-free mouse embryo (SFME) cells. Biochem Biophys Res Commun. 1990; 172: 945–51. [PUBMED], [INFOTRIEVE]
- Huaux F, Lasfargues G, Lauwerys R, Lison D. Lung toxicity of hard metal particles and production of interleukin-1, tumor necrosis factor-alpha, fibronectin, and cystatin-c by lung phagocytes. Toxicol Appl Pharmacol. 1995; 132: 53–62. [PUBMED], [INFOTRIEVE]
- Bianchi C, Donadio C, Tramonti G, Auner I, Lorusso P, Deleide G, Lunghi F, Salvadori P. Renal handling of cationic and anionic small proteins: Experiments in intact rats. Contr Nephrol. 1988; 68: 37–44
- Tenstad O, Roald A B, Grubb A, Aukland K. Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest. 1996; 56: 409–14. [PUBMED], [INFOTRIEVE]
- Thielemans N, Lauwerys R, Bernard A. Competition between albumin and low-molecular-weight proteins for renal tubular uptake in experimental nephropathies. Nephron. 1994; 66: 453–8. [PUBMED], [INFOTRIEVE]
- Thakkar H, Lowe P A, Price C P, Newman D J. Measurement of the kinetics of protein uptake by proximal tubular cells using an optical biosensor. Kidney Int. 1998; 54: 1197–205. [PUBMED], [INFOTRIEVE]
- Jacobsson B, Lignelid H, Bergerheim U S.. Transthyretin and cystatin C are catabolized in proximal tubular epithelial cells and the proteins are not useful as markers for renal cell carcinomas. Histopathology. 1995; 26: 559–64. [PUBMED], [INFOTRIEVE]
- Dieckmann T, Mitschang L, Hofmann M, Kos J, Turk V, Auerswald E A, Jaenicke R, Oschkinat H. The structures of native phosphorylated chicken cystatin and of a recombinant unphosphorylated variant in solution. J Mol Biol. 1993; 234: 1048–59. [PUBMED], [INFOTRIEVE]
- Bode W, Engh R, Musil D, Thiele U, Huber R, Karshikov A, Brzin J, Kos J, Turk V. The 2.0Å X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO J. 1988; 7: 2593–9. [PUBMED], [INFOTRIEVE]
- Ekiel I, Abrahamson M, Fulton D B, Lindahl P, Storer A C, Levadoux W, Lafrance M, Labelle S, Pomerleau Y, Groleau D, LeSauteur L, Gehring K. NMR structural studies of human cystatin C dimers and monomers. J Mol Biol. 1997; 271: 266–77. [PUBMED], [INFOTRIEVE]
- Merz G S, Benedikz E, Schwenk V, Johansen T E, Vogel L K, Rushbrook J I, Wisniewski H M. Human cystatin C forms an inactive dimer during intracellular trafficking in transfected CHO cells. J Cell Physiol. 1997; 173: 423–32. [PUBMED], [INFOTRIEVE]
- Lodish H F. Transport of secretory and membrane glycoproteins from rough endoplasmic reticulum to the Golgi. A rate-limiting step in protein maturation and secretion. J Biol Chem. 1988; 263: 2107–10. [PUBMED], [INFOTRIEVE]
- Bjarnadottir M, Nilsson C, Lindstrom V, Westman A, Davidsson P, Thormodsson F, Blondal H, Gudmundsson G, Grubb A. The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluids. Amyloid. 2001; 8: 1–10. [PUBMED], [INFOTRIEVE]
- Ekiel I, Abrahamson M. Folding-related dimerization of human cystatin C. J Biol Chem. 1996; 271: 1314–21. [PUBMED], [INFOTRIEVE]
- Silver I A, Murrills R J, Etherington D J. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res. 1988; 174: 266–76
- Jaskólski M. 3D domain swapping, protein oligomerization, and amyloid formation. Acta Biochim Pol. 2001; 48: 807–27
- Kozak M, Jankowska E, Janowski R, Grzonka Z, Grubb A, Alvarez Fernandez M, Abrahamson M, Jaskólski M. Expression of a selenomethionyl derivative and preliminary crystallographic studies of human cystatin C. Acta Crystallogr D Biol Crystallogr. 1999; 55: 1939–42. [PUBMED], [INFOTRIEVE]
- Janowski R, Kozak M, Jankowska E, Grzonka Z, Grubb A, Abrahamson M, Jaskólski M. Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nature Struct Biol. 2001; 8: 316–20. [PUBMED], [INFOTRIEVE]
- Schlunegger M P, Bennett M J, Eisenberg D. Oligomer formation by 3D domain swapping: A model for protein assembly and misassembly. Adv Protein Chem. 1997; 50: 61–122. [PUBMED], [INFOTRIEVE]
- Abrahamson M, Grubb A. Increased body temperature accelerates aggregation of the Leu-68→Gln mutant cystatin C, the amyloid-forming protein in hereditary cystatin C amyloid angiopathy. Proc Natl Acad Sci USA. 1994; 91: 1416–20. [PUBMED], [INFOTRIEVE]
- Alvarez-Fernandez M, Barrett A J, Gerhartz B, Dando P M, Ni J, Abrahamson M. Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site. J Biol Chem. 1999; 274: 19195–203. [PUBMED], [INFOTRIEVE]
- Staniforth R A, Giannini S, Higgins L D, Conroy M J, Hounslow A M, Jerala R, Craven C J, Waltho J P. Three-dimensional domain swapping in the folded and molten-globule states of cystatins, an amyloid-forming structural superfamily. EMBO J. 2001; 20: 4774–81. [PUBMED], [INFOTRIEVE]
- Liu Y, Gotte G, Libonati M, Eisenberg D. A domain-swapped RNase. A dimer with implications for amyloid formation. Nature Struct Biol. 2001; 8: 211–4. [PUBMED], [INFOTRIEVE]
- Ding F, Dokholyan N V, Buldyrev S V, Stanley H E, Shakhnovich E I. Molecular dynamics simulation of the SH3 domain aggregation suggests a generic amyloidogenesis mechanism. J Mol Biol. 2002; 324: 851–7. [PUBMED], [INFOTRIEVE]
- Knaus K J, Morillas M, Sweietnicki W, Malone M, Surewicz W K, Yee V C. Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nature Struct Biol. 2001; 8: 770–4. [PUBMED], [INFOTRIEVE]
- Sanders A, Craven C J, Higgins L D, Giannini S, Conroy M J, Hounslow A M, Waltho J P, Staniforth R A. Cystatin forms a tetramer though structural rearrangement of a domain-swapped dimers prior to amyloidogenesis. J Biol Mol. 2004; 336: 165–78
- Calero M, Pawlik M, Soto C, Castano E M, Sigurdsson E M, Kumar A, Gallo G, Frangione B, Levy E. Distinct properties of wild-type and the amyloidogenic human cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type. J Neurochem. 2001; 77: 628–37. [PUBMED], [INFOTRIEVE]
- Zerovnik E, Pompe-Novak M, Skarabot M, Ravnikar M, Musevi I, Turk V. Human stefin B readily forms amyloid fibrils in vitro. Biochim Biophys Acta. 2001, 1594; 1–5
- Martin J R, Craven C J, Jerala R, Kroon-Zitko L, Zerovnik E, Turk V, Waltho J P. The three-dimensional solution structure of human stefin A. J Mol Biol. 1995; 246: 331–43. [PUBMED], [INFOTRIEVE]
- Stubbs M T, Laber B, Bode W, Huber R, Jerala R, Lenarcic B, Turk V. The refined 2.4Å X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: A novel type of proteinase inhibitor interaction. EMBO J. 1990; 9: 1939–47. [PUBMED], [INFOTRIEVE]
- Mason R W, Sol-Church K, Abrahamson M. Amino acid substitutions in the N-terminal segment of cystatin C create selective protein inhibitors of lysosomal cysteine proteinases. Biochem J. 1998; 330: 833–8. [PUBMED], [INFOTRIEVE]
- Abrahamson M, Mason R W, Hansson H, Buttle D J, Grubb A, Ohlsson K. Human cystatin C. Role of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by leucocyte elastase. Biochem J. 1991; 273: 621–6. [PUBMED], [INFOTRIEVE]
- Hall A, Ekiel I, Mason R W, Kasprzykowski F, Grubb A, Abrahamson M. Structural basis for different inhibitory specificities of human cystatins C and D. Biochemistry. 1998; 37: 4071–9. [PUBMED], [INFOTRIEVE]
- Henskens Y M, van den, Keijbus P A, Veerman E C, Van der, Weijden G A, Timmerman M F, Snoek C M, Van der, Velden U, Nieuw Amerongen AV. Protein composition of whole and parotid saliva in healthy and periodontitis subjects. Determination of cystatins, albumin, amylase and IgA. J Periodontal Res. 1996; 31: 57–65. [PUBMED], [INFOTRIEVE]
- Hall A, Dalboge H, Grubb A, Abrahamson M. Importance of the evolutionarily conserved glycine residue in the N-terminal region of human cystatin C (Gly-11) for cysteine endopeptidase inhibition. Biochem J. 1993; 291: 123–9. [PUBMED], [INFOTRIEVE]
- Lindahl P, Ripoll D, Abrahamson M, Mort J S, Storer A C. Evidence for the interaction of valine-10 in cystatin C with the S2 subsite of cathepsin B. Biochemistry. 1994; 33: 4384–92. [PUBMED], [INFOTRIEVE]
- Gerhartz B, Ekiel I, Abrahamson M. Two stable unfolding intermediates of the disease-causing L68Q variant of human cystatin C. Biochemistry. 1998; 37: 17309–17. [PUBMED], [INFOTRIEVE]
- Abrahamson M, Dalboge H, Ólafsson I, Carlsen S, Grubb A. Efficient production of native, biologically active human cystatin C by Escherichia coli. FEBS Lett.. 1988; 236: 14–8. [PUBMED], [INFOTRIEVE]
- Shi G P, Sukhova G K, Grubb A, Ducharme A, Rhode L H, Lee R T, Ridker P M, Libby P, Chapman H A. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest. 1999; 104: 1191–7. [PUBMED], [INFOTRIEVE]
- Lindholt J S, Erlandsen E J, Henneberg E W. Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms. Br J Surg. 2001; 88: 1472–5. [PUBMED], [INFOTRIEVE]
- Jormsjo S, Wuttge D M, Sirsjo A, Whatling C, Hamsten A, Stemme S, Eriksson P. Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol. 2002; 161: 939–45. [PUBMED], [INFOTRIEVE]
- Hansen T, Petrow P K, Gaumann A, Keyszer G, Brauer R, Kriegsmann J. Synovial giant cells in rheumatoid arthritis: Expression of cystatin C, but not of cathepsin B. Exp Toxicol Pathol. 2000; 52: 312–6. [PUBMED], [INFOTRIEVE]
- Yamaza T, Tsuji Y, Goto T, Kido M A, Nishijima K, Moroi R, Akamine A, Tanaka T. Comparison in localization between cystatin C and cathepsin K in osteoclasts and other cells in mouse tibia epiphysis by immunolight and immunoelectron microscopy. Bone. 2001; 29: 42–53. [PUBMED], [INFOTRIEVE]
- Johansson L, Grubb A, Abrahamson M, Kasprzykowski F, Kasprzykowska R, Grzonka Z, Lerner U H. A peptidyl derivative structurally based on the inhibitory center of cystatin C inhibits bone resorption in vitro. Bone. 2000; 26: 451–9. [PUBMED], [INFOTRIEVE]
- Buttle D J, Abrahamson M, Burnett D, Mort J S, Barrett A J, Dando P M, Hill S L. Human sputum cathepsin B degrades proteoglycan, is inhibited by alpha 2-macroglobulin and is modulated by neutrophil elastase cleavage of cathepsin B precursor and cystatin C. Biochem J. 1991; 276: 325–31. [PUBMED], [INFOTRIEVE]
- Leung-Tack J, Tavera C, Gensac M C, Martinez J, Collé A. Modulation of phagocytosis-associated respiratory burst by human cystatin C: Role of the N-terminal tetrapeptide Lys-Pro-Pro-Arg. Exp Cell Res. 1990; 188: 16–22. [PUBMED], [INFOTRIEVE]
- Warfel A H, Cardozo C, Yoo O H, Zucker-Franklin D. Cystatin C and cathepsin B production by alveolar macrophages from smokers and nonsmokers. J Leukoc Biol. 1991; 49: 41–7. [PUBMED], [INFOTRIEVE]
- Takeyabu K, Betsuyaku T, Nishimura M, Yoshioka A, Tanino M, Miyamoto K, Kawakami Y. Cysteine proteinases and cystatin C in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Eur Respir J. 1998; 12: 1033–9. [PUBMED], [INFOTRIEVE]
- Stoka V, Nycander M, Lenarcic B, Labriola C, Cazzulo J J, Bjork I, Turk V. Inhibition of cruzipain, the major cysteine proteinase of the protozoan parasite, Trypanosoma cruzi, by proteinase inhibitors of the cystatin superfamily. FEBS Lett. 1995; 370: 101–4. [PUBMED], [INFOTRIEVE]
- Chagas J R, Authie E, Serveau C, Lalmanach G, Juliano L, Gauthier F. A comparison of the enzymatic properties of the major cysteine proteinases from Trypanosoma congolese and Trypanosoma cruzi. Mol Biochem Parasitol. 1997; 88: 85–94. [PUBMED], [INFOTRIEVE]
- Warfel A H, Zucker-Franklin D, Frangione B, Ghiso J. Constitutive secretion of cystatin C (gamma-trace) by monocytes and macrophages and its downregulation after stimulation. J Exp Med. 1987; 166: 1912–7. [PUBMED], [INFOTRIEVE]
- Barna J B, Kew R R. Inhibition of neutrophil chemotaxis by protease inhibitors. Differential effect of inhibitors of serine and thiol proteases. Inflammation. 1995; 19: 561–74. [PUBMED], [INFOTRIEVE]
- Leung-Tack J, Tavera C, Er-Raki A, Gensac M C, Collé A. Rat cystatin C: Inhibitor of granulocyte phagocytiv functions. Biol Chem Hoppe Seyler. 1990; 371(Suppl)255–8. [PUBMED], [INFOTRIEVE]
- Pierre P, Mellman I. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell. 1998; 93: 1135–45. [PUBMED], [INFOTRIEVE]
- Ono S, Shimizu N, Imai T, Mihori A, Nagao K. Increased cystatin C immunoreactivity in the skin in amyotrophic lateral sclerosis. Acta Neurol Scand. 2000; 102: 47–52. [PUBMED], [INFOTRIEVE]
- Afonso S, Tovar C, Romagnano L, Babiarz B.. Control and expression of cystatin C by mouse decidual cultures. Mol Reprod Dev. 2002; 61: 155–63. [PUBMED], [INFOTRIEVE]
- Bjorck L, Grubb A, Kjellen L. Cystatin C, a human proteinase inhibitor, blocks replication of herpes simplex virus. J Virol. 1990; 64: 941–3. [PUBMED], [INFOTRIEVE]
- Björk L. Proteinase inhibition, immunoglobulin-binding proteins and a novel antimicrobial principle. Mol Microbiol. 1990; 4: 1439–42
- Collins A R, Grubb A. Inhibitory effects of recombinant human cystatin C on human coronaviruses. Antimicrob Agents Chemother. 1991; 35: 2444–6. [PUBMED], [INFOTRIEVE]
- Naito Y, Sasaki M, Umemoto T, Namikawa I, Sakae K, Ishihara Y, Isomura S, Suzuki I. Bactericidal effect of rat cystatin S on an oral bacterium Porphyromonas gingivalis. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1995; 110: 71–5. [PUBMED], [INFOTRIEVE]
- Palm D E, Knuckey N W, Primiano M J, Spangenberger A G, Johanson C E. Cystatin C, a protease inhibitor, in degenerating rat hippocampal neurons following transient forebrain ischemia. Brain Res. 1995; 691: 1–8. [PUBMED], [INFOTRIEVE]
- Deng A, Irizarry M C, Nitsch R M, Growdon J H, Rebeck G W. Elevation of cystatin C in susceptible neurons in Alzheimer's disease. Am J Pathol. 2001; 159: 1061–8. [PUBMED], [INFOTRIEVE]
- Miyake T, Gahara Y, Nakayama M, Yamada H, Uwabe K, Kitamura T. Up-regulation of cystatin C by microglia in the rat facial nucleus following axotomy. Brain Res Mol Brain Res. 1996; 37: 273–82. [PUBMED], [INFOTRIEVE]
- Löfberg H, Grubb A O. Quantitation of gamma-trace in human biological fluids: Indications for production in the central nervous system. Scand J Clin Lab Invest. 1979; 39: 619–26
- Finney H, Newman D J, Gruber W, Merle P, Price C P. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin Chem. 1997; 43: 1016–22. [PUBMED], [INFOTRIEVE]
- Yamada T, Mukaiyama I, Miyake N, Igari J. Measurement of cystatin C in cerebrospinal fluid. Rinsho Byori. 2002; 50: 613–7. [PUBMED], [INFOTRIEVE]
- George P M, Sheat J M. Cystatin C quantification in CSF. Clin Chem. 1989; 35: 179–80. [PUBMED], [INFOTRIEVE]
- Abrahamson M, Buttle D J, Mason R W, Hansson H, Grubb A, Lilja H, Ohlsson K. Regulation of cystatin C activity by serine proteinases. Biomed Biochim Acta. 1991; 50: 587–93. [PUBMED], [INFOTRIEVE]
- Davidsson P, Folkesson S, Christiansson M, Lindbjer M, Dellheden B, Blennow K, Westman-Brinkmalm A. Identification of proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing as a prefractionation step followed by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation mass spectrometry. Rapid Commun Mass Spectrom. 2002; 16: 2083–8. [PUBMED], [INFOTRIEVE]
- Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol. 1992; 38(Suppl 1)s20–s27. [PUBMED], [INFOTRIEVE]
- Cole T, Dickson P W, Esnard F, Averill S, Risbridger G P, Gauthier F, Schreiber G. The cDNA structure and expression analysis of the genes for the cysteine proteinase inhibitor cystatin C and for beta 2-microglobulin in rat brain. Eur J Biochem. 1989; 186: 35–42. [PUBMED], [INFOTRIEVE]
- Ohe Y, Ishikawa K, Itoh Z, Tatemoto K. Cultured leptomeningeal cells secrete cerebrospinal fluid proteins. J Neurochem. 1996; 67: 964–71. [PUBMED], [INFOTRIEVE]
- Reiber H. Dynamics of brain-derived proteins in cerebrospinal fluid. Clin Chim Acta. 2001; 310: 173–86. [PUBMED], [INFOTRIEVE]
- Bollengier F. Cystatin C, alias post-gamma-globulin: A marker for multiple sclerosis?. J Clin Chem Clin Biochem. 1987; 25: 589–93. [PUBMED], [INFOTRIEVE]
- Nagai A, Murakawa Y, Terashima M, Shimode K, Umegae N, Takeuchi H, Kobayashi S. Cystatin C and cathepsin B in CSF from patients with inflammatory neurologic diseases. Neurology. 2000; 55: 1828–32. [PUBMED], [INFOTRIEVE]
- Mannes A J, Martin B M, Yang H Y, Keller J M, Lewin S, Gaiser R R, Iadarola M J. Cystatin C as a cerebrospinal fluid biomarker for pain in humans. Pain. 2003; 102: 251–6. [PUBMED], [INFOTRIEVE]
- Kubota R, Machii R, Hiratsuka N, Hotta O, Itoh Y, Kobayashi S, Shiba K. Cellulose acetate membrane electrophoresis in the analysis of urinary proteins in patients with tubulointerstitial nephritis. J Clin Lab Anal. 2003; 17: 44–51. [PUBMED], [INFOTRIEVE]
- Uchida K, Gotoh A. Measurement of cystatin-C and creatinine in urine. Clin Chim Acta. 2002; 323: 121–8. [PUBMED], [INFOTRIEVE]
- Mussap M, Fanos V, Pizzini C, Marcolongo A, Chiaffoni G, Plebani M. Predictive value of amniotic fluid cystatin C levels for the early identification of fetuses with obstructive uropathies. Br J Obst Gynecol. 2002; 109: 778–83
- Hermans C, Libotte V, Robin M, Clippe A, Wattiez R, Falmagne P, Langhendries J P, Bernard A. Maternal tobacco smoking and lung epithelium-specific proteins in amniotic fluid. Pediatr Res. 2001; 50: 487–94. [PUBMED], [INFOTRIEVE]
- Muller F, Bernard M A, Benkirane A, Ngo S, Lortat-Jacob S, Oury J F, Dommergues M. Fetal urine cystatin C as a predictor of postnatal renal function in bilateral uropathies. Clin Chem. 1999; 45: 2292–3. [PUBMED], [INFOTRIEVE]
- Collé A, Guinet R, Leclercq M, Manuel Y. Occurrence of β 2-microglobulin and post-γ -globulin in human semen. Clin Chim Acta. 1976; 67: 93
- Grubb A O, Weiber H, Lofberg H. The gamma-trace concentration of normal human seminal plasma is thirty-six times that of normal human blood plasma. Scand J Clin Lab Invest. 1983; 43: 421–5. [PUBMED], [INFOTRIEVE]
- Henskens Y M, Veerman E C, Mantel M S, van der, Velden U, Nieuw Amerongen AV. Cystatins S and C in human whole saliva and in glandular salivas in periodontal health and disease. J Dent Res. 1994; 73: 1606–14. [PUBMED], [INFOTRIEVE]
- Lie M A, Loos B G, Henskens Y M, Timmerman M F, Veerman E C, van der, Velden U, van der, Weijden G A. Salivary cystatin activity and cystatin C in natural and experimental gingivitis in smokers and non-smokers. J Clin Periodontol. 2001; 28: 979–84. [PUBMED], [INFOTRIEVE]
- Henskens Y M, Van der, Velden U, Veerman E C, Nieuw Amerongen AV. Cystatin C levels of whole saliva are increased in periodontal patients. Ann NY Acad Sci. 1993; 694: 280–2. [PUBMED], [INFOTRIEVE]
- Henskens Y M, van der, Weijden F A, van den, Keijbus P A, Veerman E C, Timmerman M F, van der, Velden U, Amerongen A V. Effect of periodontal treatment on the protein composition of whole and parotid saliva. J Periodontol. 1996; 67: 205–12. [PUBMED], [INFOTRIEVE]
- Blankenvoorde M F, Henskens Y M, van der, Weijden G A, van den, Keijbus P A, Veerman E C, Nieuw Amerongen AV. Cystatin A in gingival crevicular fluid of periodontal patients. J Periodontal Res. 1997; 32: 583–8. [PUBMED], [INFOTRIEVE]
- Blankenvoorde M F, van't, Hof W, Walgreen-Weterings E, van, Steenbergen T J, Brand H S, Veerman E C, Nieuw Amerongen AV. Cystatin and cystatin-derived peptides have antibacterial activity against the pathogen Porphyromonas gingivalis. Biol Chem. 1998; 379: 1371–5. [PUBMED], [INFOTRIEVE]
- Abrahamson M, Wikstrom M, Potempa J, Renvert S, Hall A. Modification of cystatin C activity by bacterial proteinases and neutrophil elastase in periodontitis. Mol Pathol. 1997; 50: 291–7. [PUBMED], [INFOTRIEVE]
- Hirschfeld J. Shape of the precipitate in immunoelectrophoresis. Nature. 1960; 185: 164–5. [PUBMED], [INFOTRIEVE]
- Wunderly C. Immunoelectrophoresis: Methods, interpretation, results. Adv Clin Chem. 1961; 4: 207–73. [PUBMED], [INFOTRIEVE]
- Laudel A F, Grunbaum B W, Kirk P L. Individuality of human serum by immunoelectrophoresis. Science. 1962; 137: 862–4. [PUBMED], [INFOTRIEVE]
- Grunbaum B W, Dong L. Immunoelectrophoresis with cellulose acetate. Nature. 1962; 194: 185–6. [PUBMED], [INFOTRIEVE]
- Tonnelle C, Collé A, LecLerq M, Sire J, Manuel Y. The different electrophoretic forms of post-gamma globulin, their antigenic identify and their structural availability. Biochim Biophys Acta. 1977; 490: 35–43. [PUBMED], [INFOTRIEVE]
- Ouchterlony O, Nilsson L A.. Immunodiffusion and immunoelectrophoresis, Weir D B. Handbook of Experimental Immunology. Oxford, Blackwell. 1973; 19.1–19.39
- Roelandse F W, Amons R, ter, Braak E P, Nieuwland R, van, Loon J, Souverijn J H. The high alkaline fraction on isoelectric focusing of cerebrospinal fluid is cystatin C. J Neurol Sci. 1998; 157: 105–8. [PUBMED], [INFOTRIEVE]
- Sekine T, Perry D J, Ragheeb S, Poulik M D. Radioimmunoassay (RIA) of post-gamma globulin using a monoclonal antibody. Peeters H. XXIXth Colloquium on Protides in Biological Fluids. vol. 29, New York, Pergamon Press. 1982; 769–72
- Poulik M D, Perry D J, Vokac E, Sekine T. Post-gamma globulin. II. Radioimmunoassay determination of levels of post-gamma globulin and beta 2-microglobulin. Clin Chim Acta. 1983; 128: 249–60. [PUBMED], [INFOTRIEVE]
- Joronen I, Hopsu-Havu V K, Manninen M, Rinne A, Jarvinen M, Halonen P. Detection of low molecular weight cysteine proteinase inhibitors by time-resolved fluoroimmunoassay. J Immunol Methods. 1986; 86: 243–7. [PUBMED], [INFOTRIEVE]
- Skaleric U, Babnik J, Curin V, Lah T, Turk V. Immunochemical quantitation of cysteine proteinase inhibitor cystatin C in inflamed human gingiva. Arch Oral Biol. 1989; 34: 301–5. [PUBMED], [INFOTRIEVE]
- Ouchterlony O. Quantitative immunoelectrophoresis. Acta Pathol Microbiol Scand. 1962; 154(Suppl)252–4
- Ishiguro H, Ohkubo I, Mizokami M, Titani K, Sasaki M. The use of monoclonal antibodies to define levels of cystatin C in normal human serum. Hybridoma. 1989; 8: 303–13. [PUBMED], [INFOTRIEVE]
- Collé A, Tavera C, Laurent P, Leung-Tack J, Girolami J P. Direct radioimmunoassay of rat cystatin C: Increased urinary excretion of this cysteine proteases inhibitor during chromate nephropathy. J Immunoassay. 1990; 11: 199–214
- Collé A, Tavera C, Prevot D, Leung-Tack J, Thomas Y, Manuel Y, Benveniste J, Leibowitch J. Cystatin C levels in sera of patients with human immunodeficiency virus infection. A new avidin-biotin ELISA assay for its measurement. J Immunoassay. 1992; 13: 47–60
- Pergande M, Jung K. Sandwich enzyme immunoassay of cystatin C in serum with commercially available antibodies. Clin Chem. 1993; 39: 1885–90. [PUBMED], [INFOTRIEVE]
- Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindstrom V, Grubb A. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem. 1994; 40: 1921–6. [PUBMED], [INFOTRIEVE]
- Dalboge H, Jensen E B, Tottrup H, Grubb A, Abrahamson M, Ólafsson I, Carlsen S. High-level expression of active human cystatin C in Escherichia Coli. Gene. 1989; 79: 325–32. [PUBMED], [INFOTRIEVE]
- Newman D J, Thakkar H, Edwards R G, Wilkie M, White T, Grubb A O, Price C P. Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine. Kidney Int. 1995; 47: 312–8. [PUBMED], [INFOTRIEVE]
- Mussap M, Ruzzante N, Varagnolo M, Plebani M. Quantitative automated particle-enhanced immunonephelometric assay for the routinary measurement of human cystatin C. Clin Chem Lab Med. 1998; 36: 859–65. [PUBMED], [INFOTRIEVE]
- Erlandsen E J, Randers E, Kristensen J H. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest. 1999; 59: 1–8. [PUBMED], [INFOTRIEVE]
- Bangs Laboratories. Uniform Latex Particles. Indianapolis, IN, Seradyn, Particle Technology Div. 1987; 25–34
- Lewis A V, James T J, McGuire J B, Taylor R P. Improved immunoturbidimetric assay for cystatin C. Ann Clin Biochem. 2001; 38: 111–4. [PUBMED], [INFOTRIEVE]
- McGuire J B, James T J, Taylor R P. Correction to ‘improved immunoturbidimetric assay for cystatin C.’. Ann Clin Biochem. 2001; 38: 572–3. [PUBMED], [INFOTRIEVE]
- Gorst J. Improved assay characteristics of an immunoturbidimetric assay for cystatin C. Ann Clin Biochem. 2001; 38: 153, [PUBMED], [INFOTRIEVE]
- Garrido M J, Hermida J, Tutor J C. Immunoturbidimetric assay for serum cystatin C using the Cobas Fara analyzer. Clin Chem Lab Med. 2002; 40: 853–4. [PUBMED], [INFOTRIEVE]
- Stowe H, Lawrence D, Newman D J, Lamb E J. Analytical performance of a particle-enhanced nephelometric immunoassay for serum cystatin C using rate analysis. Clin Chem. 2001; 47: 1482–5. [PUBMED], [INFOTRIEVE]
- Jensen A L, Bomholt M, Moe L. Preliminary evaluation of a particle-enhanced turbidimetric immunoassay (PETIA) for the determination of serum cystatin C-like immunoreactivity in dogs. Vet Clin Pathol. 2001; 30: 86–90. [PUBMED], [INFOTRIEVE]
- Tanaka M, Matsuo K, Enomoto M, Mizuno K. A sol particle homogeneous immunoassay for measuring serum cystatin C. Clin Biochem. 2004; 37: 27–35. [PUBMED], [INFOTRIEVE]
- Lamb E, Stowe H. Rheumatoid factor can interfere with cystatin C measurement. Ann Clin Biochem. 2003; 40: 195–6. [PUBMED], [INFOTRIEVE]
- Newman D. Rheumatoid factor can interfere with cystatin C measurement. Ann Clin Biochem. 2003; 40: 427, [PUBMED], [INFOTRIEVE]
- Bland J M, Altman D G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; i: 307–10
- Priem F, Althaus H, Jung K, Sinha P. Beta-trace protein is not better than cystatin C as an indicator of reduced glomerular filtration rate. Clin Chem. 2001; 47: 2181, [PUBMED], [INFOTRIEVE]
- Dharnidharka V R, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis. Am J Kidney Dis. 2002; 40: 221–6. [PUBMED], [INFOTRIEVE]
- Price C P, Newman D J. Light scattering immunoassay. Price C P, Newman D J. Principles and Practice of Immunoassay, 2nd ed., London, Macmillan Press. 1997; 443–80
- Jones R, Payne B. Clinical Investigation and Statistics in Laboratory Medicine. London, ACB Venture Publications. 1997; 195
- Finney H, Newman D J, Thakkar H, Fell J M, Price C P. Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children. Arch Dis Child. 2000; 82: 71–5. [PUBMED], [INFOTRIEVE]
- Harmoinen A, Ylinen E, Ala-Houhala M, Janas M, Kaila M, Kouri T. Reference intervals for cystatin C in pre- and full-term infants and children. Pediatr Nephrol. 2000; 15: 105–8. [PUBMED], [INFOTRIEVE]
- Mussap M, Plebani M, Fanos V, Bertelli L, Pesce M, Ruzzante N, Varagnolo M, Zaninotto M, Cataldi L. Serum cystatin C in healthy full-term newborns: Preliminary reference values for a promising endogenous marker of glomerular filtration rate. Prenat Neonat Med. 1997; 2: 338–42
- Plebani M, Mussap M, Bertelli L, Moggi G, Ruzzante N, Fanos V, Cataldi L. Determination of blood cystatin C in pregnant women during labor and in their newborns. Pediatr Med Chir. 1997; 19: 325–9. [PUBMED], [INFOTRIEVE]
- Cataldi L, Mussap M, Bertelli L, Ruzzante N, Fanos V, Plebani M. Cystatin C in healthy women at term pregnancy and in their infant newborns: Relationship between maternal and neonatal serum levels and reference values. Am J Perinatol. 1999; 16: 287–95. [PUBMED], [INFOTRIEVE]
- Fischbach M, Graff V, Terzic J, Bergere V, Oudet M, Hamel G. Impact of age on reference values for serum concentration of cystatin C in children. Pediatr Nephrol. 2002; 17: 104–6. [PUBMED], [INFOTRIEVE]
- Randers E, Krue S, Erlandsen E J, Danielsen H, Hansen L G. Reference interval for serum cystatin C in children. Clin Chem. 1999; 45: 1856–8. [PUBMED], [INFOTRIEVE]
- Bökenkamp A, Domanetzki M, Zinck R, Schumann G, Brodehl J. Reference values for cystatin C serum concentrations in children. Pediatr Nephrol. 1998; 12: 125–9
- Helin I, Axenram M, Grubb A. Serum cystatin C as a determinant of glomerular filtration rate in children. Clin Nephrol. 1998; 49: 221–5. [PUBMED], [INFOTRIEVE]
- Filler G, Witt I, Priem F, Ehrich J H, Jung K. Are cystatin C and beta 2-microglobulin better markers than serum creatinine for prediction of a normal glomerular filtration rate in pediatric subjects?. Clin Chem. 1997; 43: 1077–8. [PUBMED], [INFOTRIEVE]
- Filler G, Priem F, Vollmer I, Gellermann J, Jung K. Diagnostic sensitivity of serum cystatin for impaired glomerular filtration rate. Pediatr Nephrol. 1999; 13: 501–5. [PUBMED], [INFOTRIEVE]
- Galteau M M, Guyon M, Gueguen R, Siest G. Determination of serum cystatin C: Biological variation and reference values. Clin Chem Lab Med. 2001; 39: 850–7. [PUBMED], [INFOTRIEVE]
- Takuwa S, Ito Y, Ushijima K, Uchida K. Serum cystatin-C values in children by age and their fluctuation during dehydration. Pediatr Int. 2002; 44: 28–31. [PUBMED], [INFOTRIEVE]
- Bökenkamp A, Dieterich C, Schumann G. Pediatric reference values for cystatin C revisited. Pediatr Nephrol. 1999; 13: 367–8
- Bökenkamp A, Dieterich C, Dressler F, Muhlhaus K, Gembruch U, Bald R, Kirschstein M. Fetal serum concentrations of cystatin C and beta2-microglobulin as predictors of postnatal kidney function. Am J Obstet Gynecol. 2001; 185: 468–75
- Bahar A, Yilmaz Y, Unver S, Gocmen I, Karademir F. Reference values of umbilical cord and third-day cystatin C levels for determining glomerular filtration rates in newborns. J Int Med Res. 2003; 31: 231–5. [PUBMED], [INFOTRIEVE]
- Norlund L, Fex G, Lanke J, Von, Schenck H, Nilsson J E, Leksell H, Grubb A. Reference intervals for the glomerular filtration rate and cell-proliferation markers: Serum cystatin C and serum beta 2-microglobulin/cystatin C-ratio. Scand J Clin Lab Invest. 1997; 57: 463–70. [PUBMED], [INFOTRIEVE]
- Finney H, Newman D J, Price C P. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem. 2000; 37: 49–59. [PUBMED], [INFOTRIEVE]
- Erlandsen E J, Randers E, Kristensen J H. Reference intervals for serum cystatin C and serum creatinine in adults. Clin Chem Lab Med. 1998; 36: 393–7. [PUBMED], [INFOTRIEVE]
- Uhlmann E J, Hock K G, Issitt C, Sneeringer M R, Cervelli D R, Gorman R T, Scott M G. Reference intervals for plasma cystatin C in healthy volunteers and renal patients, as measured by the Dade Behring BN II System, and correlation with creatinine. Clin Chem. 2001; 47: 2031–3. [PUBMED], [INFOTRIEVE]
- Sebeková K, Krajcoviova-Kudlackova M, Schinzel R, Faist V, Klvanova J, Heidland A. Plasma levels of advanced glycation end products in healthy, long-term vegetarians and subjects on a western mixed diet. Eur J Nutr. 2001; 40: 275–81
- Vinge E, Lindergard B, Nilsson-Ehle P, Grubb A. Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. Scand J Clin Lab Invest. 1999; 59: 587–92. [PUBMED], [INFOTRIEVE]
- Keevil B G, Kilpatrick E S, Nichols S P, Maylor P W. Biological variation of cystatin C: Implications for the assessment of glomerular filtration rate. Clin Chem. 1998; 44: 1535–9. [PUBMED], [INFOTRIEVE]
- Cimerman N, Brguljan P M, Krasovec M, Suskovic S, Kos J. Twenty-four hour variations of cystatin C and total cysteine proteinase inhibitory activity in sera from healthy subjects. Clin Chim Acta. 2000; 29: 89–95
- Finney H, Newman D J, Redman C WG, Price C P. Cystatin C and pre-eclampsia. “Focus 98”. Nat Meet Assoc Clin Biochem Glasgow. 1998
- Bökenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J. Cystatin C—a new marker of glomerular filtration rate in children independent of age and height. Pediatrics. 1998; 101: 875–81
- Bernier G M, Cohen R J, Conrad M E. Microglobulinaemia in renal failure. Nature. 1968; 218: 598–9. [PUBMED], [INFOTRIEVE]
- Jung K, Schulze B D, Sydow K, Pergrande M, Precht K, Schreiber G. Diagnostic value of low-molecular mass proteins in serum for the detection of reduced glomerular filtration rate. J Clin Chem Clin Biochem. 1987; 25: 499–503. [PUBMED], [INFOTRIEVE]
- Acchiardo S, Kraus A P, Jennings B R. β2-Microglobulin levels in patients with renal insufficiency. Am J Kidney Dis. 1989; 13: 70–4. [PUBMED], [INFOTRIEVE]
- Trollfors B, Norrby R. Estimation of glomerular filtration rate by serum creatinine and serum β2-microglobulin. Nephron. 1981; 28: 196–9. [PUBMED], [INFOTRIEVE]
- Sturfelt G, Truedsson H, Thysell H, Björk S. Serum level of complement factor D in systemic lupus erythematosus—an indicator of glomerular filtration rate. Acta Med Scand. 1984; 216: 171–7. [PUBMED], [INFOTRIEVE]
- Renkin E M, Robinson R R. Glomerular filtration. N Engl J Med. 1974; 290: 785–9. [PUBMED], [INFOTRIEVE]
- Lavender S, Hilton P J, Jones N F. The measurement of glomerular filtration rate in renal disease. Lancet. 1969; i: 1216–9
- Alving A S, Miller B F. A practical method for the measurement of glomerular filtration rate (inulin clearance) with an evaluation of the clinical significance of this determination. Arch Int Med. 1940; 66: 306–10
- Garnett E S, Parsons V, Veall N. Measurement of glomerular filtration rate in man using a Cr-51/edetic acid complex. Lancet. 1967; i: 818–21
- Anderson C F, Sawyer T K, Cutler R E. Iothalamate sodium 125I vs cyanocobalamin 57Co as a measure of glomerular filtration rate in man. JAMA. 1968; 204: 653–8
- Dayton D A, Maher F T, Elveback L R. Renal clerance of technetium (Tc-99m) as pertechnetate. Mayo Clin Proc. 1969; 44: 549–52. [PUBMED], [INFOTRIEVE]
- Gaspari F, Perico N, Ruggenenti P, Mosconi L, Amuchastegui C S, Guerini E, Daina E, Remuzzi G. Plasma clearance of nonradioactive Iohexol as a measure of glomerular filtration rate. J Am Soc Nephrol. 1995; 6: 257–63. [PUBMED], [INFOTRIEVE]
- Smith H W. The reliability of inulin as a measure of glomerular filtration rate. Smith H W. The Kidney: Structure and Function in Health and Disease. New York, Oxford University Press. 1955; 231–8
- Swan S K. The search continues—an ideal marker of GFR. Clin Chem. 1997; 43: 913–4. [PUBMED], [INFOTRIEVE]
- Perrone R D, Madias N E, Levey A S. Serum creatinine as an index of renal function: New insights into old concepts. Clin Chem. 1992; 38: 1933–53. [PUBMED], [INFOTRIEVE]
- Levey A S, Berg R L, Gassman J J, Hall P M, Walker W G. Creatinine filtration, secretion and excretion during progressive renal disease. Kidney Int. 1989; 36(Suppl 27)s37–s80
- Brochner-Mortensen J, Rodbro P. Selection of routine method for determination of glomerular filtration rate in adults. Scand J Clin Lab Invest. 1976; 36: 35–43. [PUBMED], [INFOTRIEVE]
- Gabriel R. Time to scrap creatinine clearance?. Br Med J. 1986; 293: 1119–20
- Hoffmann A, Nimtz M, Conradt H S. Molecular characterization of β -trace protein in human serum and urine: A potential diagnostic marker for renal diseases. Glycobiology. 1997; 7: 499–506. [PUBMED], [INFOTRIEVE]
- Priem F, Althaus H, Birnbaum M, Sinha P, Conradt H S, Jung K. β -Trace protein in serum: A new marker of glomerular filtration rate in the creatinine-blind range. Clin Chem. 1999; 45: 567–8. [PUBMED], [INFOTRIEVE]
- Laterza O F, Price C P, Scott M G. Cystatin C: An improved estimator of glomerular filtration rate?. Clin Chem. 2002; 48: 699–707. [PUBMED], [INFOTRIEVE]
- Grubb A, Simonsen O, Sturfelt G, Truedsson L, Thysell H. Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate. Acta Med Scand. 1985; 218: 499–503. [PUBMED], [INFOTRIEVE]
- Simonsen O, Grubb A, Thysell H. The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate. Scand J Clin Lab Invest. 1985; 45: 97–101. [PUBMED], [INFOTRIEVE]
- Nancy A, Obuchowski, Michael L Lieber, Frank H Wians, Jr.. ROC curves in clinical chemistry: Uses, misuses, and possibile solutions. Clin Chem. 2004; 50: 1118–25
- Nergelius G, Lidgren L, Grubb A, Vinge E. Renal dysfunction after total knee replacement is not aggravated by bone cement. Acta Anaesthesiol Scand. 1998; 42: 974–81. [PUBMED], [INFOTRIEVE]
- Fraser J S, Muller A F, Smith D J, Newman D J, Lamb E J. Renal tubular injury is present in acute inflammatory bowel disease prior to the introduction of drug therapy. Aliment Pharmacol Ther. 2001; 15: 1131–7. [PUBMED], [INFOTRIEVE]
- Katzmann J A, Clark R J, Abraham R S, Bryant S, Lymp J F, Bradwell A R, Kyle R A. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: Relative sensitivity for detection of monoclonal light chains. Clin Chem. 2002; 48: 1437–44. [PUBMED], [INFOTRIEVE]
- Gunther A, Burchard G D, Slevogt H, Abel W, Grobusch M P. Renal dysfunction in falciparum—malaria is detected more often when assessed by serum concentration of cystatin C instead of creatinine. Trop Med Int Health. 2002; 7: 931–4. [PUBMED], [INFOTRIEVE]
- Sarasua S M, Mueller P, Kathman S, Campagna D, Uddin M S, White M C. Confirming the utility of four kidney biomarker tests in a longitudinal follow-up study. Ren Fail. 2003; 25: 797–817. [PUBMED], [INFOTRIEVE]
- Olivieri O, Bassi A, Pizzolo F, Tinazzi E, Corrocher R. Cystatin C versus creatinine in renovascular disease. Clin Chem. 2002; 48: 2256–9. [PUBMED], [INFOTRIEVE]
- Tomino Y, Suzuki S, Gohda T, Kobayashi M, Horikoshi S, Imai H, Saito T, Kawamura T, Yorioka N, Harada T, Yasumoto Y, Kida H, Kobayashi Y, Endoh M, Sato H, Saito K. Serum cystatin C may predict the prognostic stages of patients with IgA nephropathy prior to renal biopsy. J Clin Lab Anal. 2001; 15: 25–9. [PUBMED], [INFOTRIEVE]
- Tian S, Kusano E, Ohara T, Tabei K, Itoh Y, Kawai T, Asano Y. Cystatin C measurement and its practical use in patients with various renal diseases. Clin Nephrol. 1997; 48: 104–8. [PUBMED], [INFOTRIEVE]
- Herget-Rosenthal S, Trabold S, Pietruck F, Holtmann M, Philipp T, Kribben A. Cystatin C: Efficacy as screening test for reduced glomerular filtration rate. Am J Nephrol. 2000; 20: 97–102. [PUBMED], [INFOTRIEVE]
- Jenkins M A, Brown D J, Ierino F L, Ratnaike S I. Cystatin C for estimation of glomerular filtration rate in patients with spinal cord injury. Ann Clin Biochem. 2003; 40: 364–8. [PUBMED], [INFOTRIEVE]
- Shimizu-Tokiwa A, Kobata M, Io H, Kobayashi N, Shou I, Funabiki K, Fukui M, Horikoshi S, Shirato I, Saito K, Tomino Y. Serum cystatin C is a more sensitive marker of glomerular function than serum creatinine. Nephron. 2002; 92: 224–6. [PUBMED], [INFOTRIEVE]
- Meier P, Froidevaux C, Dayer E, Blanc E. Cystatin C concentration and glomerular filtration rate. Lancet. 2001; 357: 634–5. [PUBMED], [INFOTRIEVE]
- John G T, Fleming J J, Talaulikar G S, Selvakumar R, Thomas P P, Jacob C K. Measurement of renal function in kidney donors using serum cystatin C and beta(2)-microglobulin. Ann Clin Biochem. 2003; 40: 656–8. [PUBMED], [INFOTRIEVE]
- Nilsson-Ehle P, Grubb A. New markers for the determination of GFR: Iohexol clearance and cystatin C serum concentration. Kidney Int. 1994; 47: s17–s19
- Newman D J, Thakkar H, Edwards R G, Wilkie M, White T, Grubb A O, Price C P. Serum cystatin C: A replacement for creatinine as a biochemical marker of GFR. Kidney Int. 1994; 47(Suppl)s20–s21
- Randers E, Kristensen J H, Erlandsen E J, Danielsen H. Serum cystatin C as a marker of the renal function. Scand J Clin Lab Invest. 1998; 58: 585–92. [PUBMED], [INFOTRIEVE]
- Coll E, Botey A, Alvarez L, Poch E, Quinto L, Saurina A, Vera M, Piera C, Darnell A. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000; 36: 29–34. [PUBMED], [INFOTRIEVE]
- Randers E, Erlandsen E J, Pedersen O L, Hasling C, Danielsen H. Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function. Clin Nephrol. 2000; 54: 203–9. [PUBMED], [INFOTRIEVE]
- Woitas R P, Stoffel-Wagner B, Poege U, Schiedermaier P, Spengler U, Sauerbruch T. Low-molecular weight proteins as markers for glomerular filtration rate. Clin Chem. 2001; 47: 2179–80. [PUBMED], [INFOTRIEVE]
- Kazama J J, Kutsuwada K, Ataka K, Maruyama H, Gejyo F. Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases. Nephron. 2002; 91: 13–20. [PUBMED], [INFOTRIEVE]
- Thomassen S A, Johannesen I L, Erlandsen E J, Abrahamsen J, Randers E. Serum cystatin C as a marker of the renal function in patients with spinal cord injury. Spinal Cord. 2002; 40: 524–8. [PUBMED], [INFOTRIEVE]
- Nitta K, Hayashi T, Uchida K, Honda K, Tsukada M, Sekine S, Itabashi M, Yumura W, Nihei H. Serum cystatin C concentration as a marker of glomerular filtration rate in patients with various renal diseases. Intern Med. 2002; 41: 931–5. [PUBMED], [INFOTRIEVE]
- Donadio C, Lucchesi A, Ardini M, Donadio E, Giordani R. Serum levels of beta-trace protein and glomerular filtration rate-preliminary results. J Pharm Biomed Anal. 2003; 32: 1099–104. [PUBMED], [INFOTRIEVE]
- Harmoinen A, Lehtimaki T, Korpela M, Turjanmaa V, Saha H. Diagnostic accuracies of plasma creatinine, cystatin C, and glomerular filtration rate calculated by the Cockcroft-Gault and Levey (MDRD) formulas. Clin Chem. 2003; 49: 1223–5. [PUBMED], [INFOTRIEVE]
- Hoek F J, Kemperman F A, Krediet R T. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant. 2003; 18: 2024–31. [PUBMED], [INFOTRIEVE]
- Chantrel F, Agin A, Offner M, Koehl C, Moulin B, Hannedouche T. Comparison of cystatin C versus creatinine for detection of mild renal failure. Clin Nephrol. 2000; 54: 374–81. [PUBMED], [INFOTRIEVE]
- Donadio C, Lucchesi A, Ardini M, Giordani R. Cystatin C, beta 2-microglobulin, and retinol-binding protein as indicators of glomerular filtration rate: Comparison with plasma creatinine. J Pharm Biomed Anal. 2001; 24: 835–42. [PUBMED], [INFOTRIEVE]
- Schuck O, Teplan V, Jabor A, Stollova M, Skibova J. Glomerular filtration rate estimation in patients with advanced chronic renal insufficiency based on serum cystatin C levels. Nephron Clin Pract. 2003; 93: c146–51. [PUBMED], [INFOTRIEVE]
- Jung K, Jung M. Cystatin C: A promising marker of glomerular filtration rate to replace creatinine. Nephron. 1995; 70: 370–1. [PUBMED], [INFOTRIEVE]
- Hayashi T, Nitta K, Hatano M, Nakauchi M, Nihei H. The serum cystatin C concentration measured by particle-enhanced immunonephelometry is well correlated with inulin clearance in patients with various types of glomerulonephritis. Nephron. 1999; 82: 90–2. [PUBMED], [INFOTRIEVE]
- Schwartz G J, Haycock G B, Edelmann C M, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976; 58: 259–63. [PUBMED], [INFOTRIEVE]
- Ylinen E A, Ala-Houhala M, Harmoinen A P, Knip M. Cystatin C as a marker for glomerular filtration rate in pediatric patients. Pediatr Nephrol. 1999; 13: 506–9. [PUBMED], [INFOTRIEVE]
- Kilpatrick E S, Keevil B G, Addison G M. Does adjustment of GFR to extracellular fluid volume improve the clinical utility of cystatin C?. Arch Dis Child. 2000; 82: 499–502. [PUBMED], [INFOTRIEVE]
- Filler G, Priem F, Lepage N, Sinha P, Vollmer I, Clark H, Keely E, Matzinger M, Akbari A, Althaus H, Jung K. Beta-trace protein, cystatin C, beta(2)-microglobulin, and creatinine compared for detecting impaired glomerular filtration rates in children. Clin Chem. 2002; 48: 729–36. [PUBMED], [INFOTRIEVE]
- Pham-Huy A, Leonard M, Lepage N, Halton J, Filler G. Measuring glomerular filtration rate with cystatin C and beta-trace protein in children with spina bifida. J Urol. 2003; 169: 2312–5. [PUBMED], [INFOTRIEVE]
- Willems H L, Hilbrands L B, van de, Calseyde J F, Monnens L A, Swinkels D W. Is serum cystatin C the marker of choice to predict glomerular filtration rate in paediatric patients?. Ann Clin Biochem. 2003; 40: 60–4. [PUBMED], [INFOTRIEVE]
- Martini S, Prevot A, Mosig D, Werner D, van, Melle G, Guignard J P. Glomerular filtration rate: Measure creatinine and height rather than cystatin C!. Acta Paediatr. 2003; 92: 1052–7. [PUBMED], [INFOTRIEVE]
- Stickle D, Cole B, Hock K, Hruska K A, Scott M G. Correlation of plasma concentrations of cystatin C and creatinine to inulin clearance in a pediatric population. Clin Chem. 1998; 44: 1334–8. [PUBMED], [INFOTRIEVE]
- Montini G, Cosmo L, Amici G, Mussap M, Zacchello G. Plasma cystatin C values and inulin clearances in premature neonates. Pediatr Nephrol. 2001; 16: 463–5. [PUBMED], [INFOTRIEVE]
- Filler G, Lepage N. Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula?. Pediatr Nephrol. 2003; 18: 981–5. [PUBMED], [INFOTRIEVE]
- National Kidney Foundation, K/DOQ1 Clinical practice guidelines for chronic kidney disease: Evaluation, stratification and classification. Am J Kidney Dis. 2002; 39: s1–s266
- Finney H, Bates C J, Price C P. Plasma cystatin C determinations in a healthy elderly population. Arch Gerontol Geriatr. 1999; 29: 75–94. [PUBMED], [INFOTRIEVE]
- Wasen E, Suominen P, Isoaho R, Mattila K, Virtanen A, Kivela S L, Irjala K. Serum cystatin C as a marker of kidney dysfunction in an elderly population. Clin Chem. 2002; 48: 1138–40. [PUBMED], [INFOTRIEVE]
- Johnston N, Jernberg T, Lindahl B, Lindbäck J, Stridsberg M, Larsson A, Venge P, Wallentin L. Biochemical indicators of cardiac and renal function in a healthy elderly population. Clin Biochem. 2004; 37: 210–6. [PUBMED], [INFOTRIEVE]
- Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis. 2001; 37: 79–83. [PUBMED], [INFOTRIEVE]
- O'Riordan S E, Webb M C, Stowe H J, Simpson D E, Kandarpa M, Coakley A J, Newman D J, Saunders J A, Lamb E J. Cystatin C improves the detection of mild renal dysfunction in older patients. Ann Clin Biochem. 2003; 40: 648–55. [PUBMED], [INFOTRIEVE]
- O'Riordan S, Ouldred E, Brice S, Jackson S H, Swift C G. Serum cystatin C is not a better marker of creatinine or digoxin clearance than serum creatinine. Br J Clin Pharmacol. 2002; 53: 398–402. [PUBMED], [INFOTRIEVE]
- Van Den, Noortgate N J, Janssens W H, Delanghe J R, Afschrift M B, Lameire N H. Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old old. J Am Geriatr Soc. 2002; 50: 1278–82. [PUBMED], [INFOTRIEVE]
- Burkhardt H, Bojarsky G, Gladisch R. Diagnostic efficiency of cystatin C and serum creatinine as markers of reduced glomerular filtration rate in the elderly. Clin Chem Lab Med. 2002; 40: 1135–8. [PUBMED], [INFOTRIEVE]
- Lamb E J, O'Riordan S E, Newman D J, Webb M C. Serum cystatin C may be a better marker of renal impairment than creatinine. J Am Geriatr Soc. 2003; 51: 1674, [PUBMED], [INFOTRIEVE]
- Burkhardt H, Bojarsky G, Gretz N, Gladisch R. Creatinine clearance, Cockcroft-Gault formula and cystatin C: Estimators of true glomerular filtration rate in the elderly?. Gerontology. 2002; 48: 140–6. [PUBMED], [INFOTRIEVE]
- Wasen E, Isoaho R, Mattila K, Vahlberg T, Kivela S L, Irjala K. Serum cystatin C in the aged: Relationships with health status. Am J Kidney Dis. 2003; 42: 36–43. [PUBMED], [INFOTRIEVE]
- Heikkinen E, Waters W E, Brzezinski Z J, The elderly in eleven countries, A sociomedical survey, in Public Health in Europe 21. CopenhagenDenmark, World Health Organization. 1983; 161–231
- Lamb E J, O'Riordan S E, Delaney M P. Kidney function in older people: Pathology, assessment and management. Clin Chim Acta. 2003; 334: 25–40. [PUBMED], [INFOTRIEVE]
- Nicholson M L, McCulloch T A, Harper S J, Wheatley T J, Edwards C M, Feehally J, Furness P N. Early measurement of interstitial fibrosis predicts long-term renal function and graft survival in renal transplantation. Br J Surg. 1996; 83: 1082–5. [PUBMED], [INFOTRIEVE]
- Filler G, Browne R, Seikaly M G. Glomerular filtration rate as a putative ‘surrogate end-point’ for renal transplant clinical trials in children. Pediatr Transplant. 2003; 7: 18–24. [PUBMED], [INFOTRIEVE]
- Plebani M, Dall'Amico R, Mussap M, Montini G, Ruzzante N, Marsilio R, Giordano G, Zacchello G. Is serum cystatin C a sensitive marker of glomerular filtration rate (GFR)? A preliminary study on renal transplant patients. Ren Fail. 1998; 20: 303–9. [PUBMED], [INFOTRIEVE]
- Risch L, Blumberg A, Huber A.. Rapid and accurate assessment of glomerular filtration rate in patients with renal transplants using serum cystatin C. Nephrol Dial Transplant. 1999; 14: 1991–6. [PUBMED], [INFOTRIEVE]
- Le, Bricon T, Thervet E, Froissart M, Benlakehal M, Bousquet B, Legendre C, Erlich D. Plasma cystatin C is superior to 24-h creatinine clearance and plasma creatinine for estimation of glomerular filtration rate 3 months after kidney transplantation. Clin Chem. 2000; 46: 1206–7. [PUBMED], [INFOTRIEVE]
- Paskalev E, Lambreva L, Simeonov P, Koicheva N, Beleva B, Genova M, Marcovska R, Nashkov A. Serum cystatin C in renal transplant patients. Clin Chim Acta. 2001; 310: 53–6. [PUBMED], [INFOTRIEVE]
- Risch L, Blumberg A, Huber A R. Assessment of renal function in renal transplant patients using cystatin C. A comparison to other renal function markers and estimates. Ren Fail. 2001; 23: 439–48. [PUBMED], [INFOTRIEVE]
- Filler G, Pham-Huy A. Cystatin C should be measured in pediatric renal transplant patients!. Pediatr Transplant. 2002; 6: 357–60. [PUBMED], [INFOTRIEVE]
- Christensson A, Ekberg J, Grubb A, Ekberg H, Lindstrom V, Lilja H. Serum cystatin C is a more sensitive and more accurate marker of glomerular filtration rate than enzymatic measurements of creatinine in renal transplantation. Nephron Physiol. 2003; 94: 19–27
- Thervet E, Le, Bricon T, Hugot V, Benlakehal M, Bedrossian J, Beuzard Y, Legendre C, Erlich D. Early diagnosis of renal function recovery by cystatin C in renal allograft recipients. Transplant Proc. 2000; 32: 2779, [PUBMED], [INFOTRIEVE]
- Leach T D, Kitiyakara C, Price C P, Stevens J M, Newman D J. Prognostic significance of serum cystatin c concentrations in renal transplant recipients: 5–year follow-up. Transplant Proc. 2002; 34: 1152–8. [PUBMED], [INFOTRIEVE]
- Krieser D, Rosenberg A R, Kainer G, Naidoo D. The relationship between serum creatinine, serum cystatin C and glomerular filtration rate in pediatric renal transplant recipients: A pilot study. Pediatr Transplant. 2002; 6: 392–5. [PUBMED], [INFOTRIEVE]
- Pöge U, Stoschus B, Stoffel-Wagner B, Gerhardt T, Klehr H U, Sauerbruch T, Woitas R P. Cystatin C as an endogenous marker of glomerular filtration rate in renal transplant patients. Kidney Blood Press Res. 2003; 26: 55–60
- Herget-Rosenthal S, Trabold S, Huesing J, Heemann U, Philipp T, Kribben A. Cystatin C—an accurate marker of glomerular filtration rate after renal transplantation?. Transpl Int. 2000; 13: 285–9. [PUBMED], [INFOTRIEVE]
- Li F K, Ho S K, Yip T P, Tse K C, Chan T M, Lai K N. Cystatin C assay for the detection of renal dysfunction in Chinese renal transplant recipients. Clin Chim Acta. 2002; 322: 133–7. [PUBMED], [INFOTRIEVE]
- Le, Bricon T, Thervet E, Benlakehal M, Bousquet B, Legendre C, Erlich D. Changes in plasma cystatin C after renal transplantation and acute rejection in adults. Clin Chem. 1999; 45: 2243–9. [PUBMED], [INFOTRIEVE]
- Hermida J, Romero R, Tutor J C. Relationship between serum cystatin C and creatinine in kidney and liver transplant patients. Clin Chim Acta. 2002; 316: 165–70. [PUBMED], [INFOTRIEVE]
- Bökenkamp A, Ozden N, Dieterich C, Schumann G, Ehrich J H, Brodehl J. Cystatin C and creatinine after successful kidney transplantation in children. Clin Nephrol. 1999; 52: 371–6
- Bostom A G, Gohh R Y, Morrissey P. Hyperhomocysteinemia in chronic renal transplant recipients. Graft. 2000; 3: 195–204
- Ducloux D, Motte G, Challier B, Gibey R, Chalopin J. Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: A prospective study. J Am Soc Nephrol. 2000; 11: 134–7. [PUBMED], [INFOTRIEVE]
- Norlund L, Grubb A, Fex G, Leksell H, Nilsson J E, Schenck H, Hultberg B. The increase of plasma homocysteine concentrations with age is partly due to the deterioration of renal function as determined by plasma cystatin C. Clin Chem Lab Med. 1998; 36: 175–8. [PUBMED], [INFOTRIEVE]
- Aras O, Tsai M Y, Hanson N Q, Bailey R, Rao G, Hunninghake D B. Cystatin C is an independent predictor of fasting and post-methionine load total homocysteine concentrations among stable renal transplant recipients. Clin Chem. 2001; 47: 1263–8. [PUBMED], [INFOTRIEVE]
- Han H, Dwyer J T, Selhub J, Jacques P F, Houser R F, Park J H, Kim Y S, Bang B K, Kim S, Jung K A, Chang Y K, Bostom A G. Serum cystatin C is an independent predictor of total homocysteine levels in stable Korean renal transplant recipients with normal serum creatinine. J Ren Nutr. 2001; 11: 149–54. [PUBMED], [INFOTRIEVE]
- Bostom A G, Bausserman L, Jacques P F, Liaugaudas G, Selhub J, Rosenberg I H. Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine. Arterioscler Thromb Vasc Biol. 1999; 19: 2241–4. [PUBMED], [INFOTRIEVE]
- Bostom A G, Gohh R Y, Bausserman L, Hakas D, Jacques P F, Selhub J, Dworkin L, Rosenberg I H. Serum cystatin C as a determinant of fasting total homocysteine levels in renal transplant recipients with a normal serum creatinine. J Am Soc Nephrol. 1999; 10: 164–6. [PUBMED], [INFOTRIEVE]
- Abdella N, Mojiminiyi O A, Akanji A O.. Homocysteine and endogenous markers of renal function in type 2 diabetic patients without coronary heart disease. Diabetes Res Clin Pract. 2000; 50: 177–85. [PUBMED], [INFOTRIEVE]
- Anwar W, Gueant J L, Abdelmouttaleb I, Adjalla C, Gerard P, Lemoel G, Erraess N, Moutabarrek A, Namour F. Hyperhomocysteinemia is related to residual glomerular filtration and folate, but not to methylenetetrahydrofolate-reductase and methionine synthase polymorphisms, in supplemented end-stage renal disease patients undergoing hemodialysis. Clin Chem Lab Med. 2001; 39: 747–52. [PUBMED], [INFOTRIEVE]
- Budge M M, de, Jager C, Hogervorst E, Smith A D. Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people. J Am Geriatr Soc. 2002; 50: 2014–8. [PUBMED], [INFOTRIEVE]
- Nilsson K, Gustafson L, Hultberg B. Role of impaired renal function as a cause of elevated plasma homocysteine concentration in psychogeriatric patients. Scand J Clin Lab Invest. 2002; 62: 385–9. [PUBMED], [INFOTRIEVE]
- Rauh M, Verwied S, Knerr I, Dorr H G, Sonnichsen A, Koletzko B. Homocysteine concentrations in a German cohort of 500 individuals: Reference ranges and determinants of plasma levels in healthy children and their parents. Amino Acids. 2001; 20: 409–18. [PUBMED], [INFOTRIEVE]
- Jonasson T, Ohlin H, Andersson A, Arnadottir M, Hultberg B. Renal function exerts only a minor influence on high plasma homocysteine concentrations in patients with acute coronary syndromes. Clin Chem Lab Med. 2002; 40: 137–42. [PUBMED], [INFOTRIEVE]
- Bökenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J. Cystatin C serum concentrations underestimate glomerular filtration rate in renal transplant recipients. Clin Chem. 1999; 45: 1866–8
- Marcen R, Ting A, Taylor C J, Miach P J, Chapman J R, Morris P J. Immunoglobulin class and specificity of lymphocytotoxic antibodies after kidney transplantation. Nephrol Dial Transplant. 1988; 3: 809–13. [PUBMED], [INFOTRIEVE]
- Hermida J, Romero R, Tutor J C. Serum cystatin C-immunoglobulin high-molecular-weight complexes in kidney and liver transplant patients. Kidney Int. 2001; 60: 1561–4. [PUBMED], [INFOTRIEVE]
- Risch L, Huber A R. Serum cystatin C in transplantation. Kidney Int. 2002; 61: 1548, [PUBMED], [INFOTRIEVE]
- Cimerman N, Brguljan P M, Krasovec M, Suskovic S, Kos J. Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients. Clin Chim Acta. 2000; 300: 83–95. [PUBMED], [INFOTRIEVE]
- Risch L, Herklotz R, Blumberg A, Huber A R. Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem. 2001; 47: 2055–9. [PUBMED], [INFOTRIEVE]
- Bökenkamp A, van, Wijk J A, Lentze M J, Stoffel-Wagner B. Effect of corticosteroid therapy on serum cystatin C and beta2-microglobulin concentrations. Clin Chem. 2002; 48: 1123–6
- Risch L, Huber A R.. Glucocorticoids and increased serum cystatin C concentrations. Clin Chim Acta. 2002; 320: 133–4. [PUBMED], [INFOTRIEVE]
- Ritz E, Rychlík I, Locatelli F, Halimi S. End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. Am J Kidney Dis. 1999; 34: 795–808. [PUBMED], [INFOTRIEVE]
- Ritz E, Orth S R. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med. 1999; 341: 1127–33. [PUBMED], [INFOTRIEVE]
- Jacobs C, Selwood N H. Renal replacement therapy for end-stage renal failure in France: Current status and evolutive trends over the last decade. Am J Kidney Dis. 1995; 25: 188–95. [PUBMED], [INFOTRIEVE]
- Piwowar A, Knapik-Kordecka M, Buczynska H, Warwas M. Plasma cystatin C concentration in non-insulin-dependent diabetes mellitus: Relation with nephropathy. Arch Immunol Ther Exp (Warsz). 1999; 47: 327–31
- Harmoinen A P, Kouri T T, Wirta O R, Lehtimaki T J, Rantalaiho V, Turjanmaa V M, Pasternack A I. Evaluation of plasma cystatin C as a marker for glomerular filtration rate in patients with type 2 diabetes. Clin Nephrol. 1999; 52: 363–70. [PUBMED], [INFOTRIEVE]
- Mojiminiyi O A, Abdella N, George S. Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with type 2 diabetes mellitus. Scand J Clin Lab Invest. 2000; 60: 483–9. [PUBMED], [INFOTRIEVE]
- Mussap M, Dalla, Vestra M, Fioretto P, Saller A, Varagnolo M, Nosadini R, Plebani M. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int. 2002; 61: 1453–61. [PUBMED], [INFOTRIEVE]
- Tan G D, Lewis A V, James T J, Altmann P, Taylor R P, Levy J C. Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: Reproducibility and accuracy compared with standard measures and iohexol clearance. Diabetes Care. 2002; 25: 2004–9. [PUBMED], [INFOTRIEVE]
- Perlemoine C, Beauvieux M C, Rigalleau V, Baillet L, Barthes N, Derache P, Gin H. Interest of cystatin C in screening diabetic patients for early impairment of renal function. Metabolism. 2003; 52: 1258–64. [PUBMED], [INFOTRIEVE]
- Buysschaert M, Joudi I, Wallemacq P, Hermans M P. Comparative performance of serum cystatin-c versus serum creatinine in diabetic subjects. Diabetes Metab. 2003; 29: 377–83. [PUBMED], [INFOTRIEVE]
- Shimizu A, Horikoshi S, Rinnno H, Kobata M, Saito K, Tomino Y. Serum cystatin C may predict the early prognostic stages of patients with type 2 diabetic nephropathy. J Clin Lab Anal. 2003; 17: 164–7. [PUBMED], [INFOTRIEVE]
- Oddoze C, Morange S, Portugal H, Berland Y, Dussol B. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes. Am J Kidney Dis. 2001; 38: 310–6. [PUBMED], [INFOTRIEVE]
- Mojiminiyi O A, Abdella N. Evaluation of cystatin C and beta-2 microglobulin as markers of renal function in patients with type 2 diabetes mellitus. J Diabetes Complications. 2003; 17: 160–8. [PUBMED], [INFOTRIEVE]
- Buysschaert M, Joudi I, Wallemacq P, Hermans M P. Performance of serum cystatin-C versus serum creatinine in subjects with type 1 diabetes. Diabetes Care. 2003; 26: 1320, [PUBMED], [INFOTRIEVE]
- Levy J, Morris R, Hammersley M, Turner R.. Discrimination, adjusted correlation, and equivalence of imprecise tests: Application to glucose tolerance. Am J Physiol. 1999; 276: E365–E375. [PUBMED], [INFOTRIEVE]
- Ambrosch A, Dierkes J, Lobmann R, Kuhne W, Konig W, Luley C, Lehnert H. Relation between homocysteinaemia and diabetic neuropathy in patients with Type 2 diabetes mellitus. Diabet Med. 2001; 18: 185–92. [PUBMED], [INFOTRIEVE]
- Ozmen B, Ozmen D, Turgan N, Habif S, Mutaf I, Bayindir O. Association between homocysteinemia and renal function in patients with type 2 diabetes mellitus. Ann Clin Lab Sci. 2002; 32: 279–86. [PUBMED], [INFOTRIEVE]
- Holmquist P, Torffvit O, Sjoblad S. Metabolic status in diabetes mellitus affects markers for glomerular filtration rate. Pediatr Nephrol. 2003; 18: 536–40. [PUBMED], [INFOTRIEVE]
- Möller S, Henriksen J H. Circulatory abnormalities in cirrhosis with focus on neurohumoral aspects. Semin Nephrol. 1997; 17: 505–19
- Caregaro L, Menon F, Angeli P, Amodio P, Merkel C, Bortoluzzi A, Alberino F, Gatta A. Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Arch Intern Med. 1994; 154: 201–5. [PUBMED], [INFOTRIEVE]
- DeSanto N G, Anastasio P, Loguercio C, Spitali L, Del, Vecchio Blanco C, Corvinelli M, Girillo M. Creatinine clearance: An inadequate marker of renal filtration in patients with early posthepatitic cirrhosis (Child A) without fluid retention and muscle wasting. Nephron. 1995; 70: 421–4. [PUBMED], [INFOTRIEVE]
- Woitas R P, Stoffel-Wagner B, Flommersfeld S, Poege U, Schiedermaier P, Klehr H U, Spengler U, Bidlingmaier F, Sauerbruch T. Correlation of serum concentrations of cystatin C and creatinine to inulin clearance in liver cirrhosis. Clin Chem. 2000; 46: 712–5. [PUBMED], [INFOTRIEVE]
- Demirtas S, Bozbas A, Akbay A, Yavuz Y, Karaca L. Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome. Clin Chim Acta. 2001; 311: 81–9. [PUBMED], [INFOTRIEVE]
- Orlando R, Mussap M, Plebani M, Piccoli P, de, Martin S, Floreani M, Padrini R, Palatini P. Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem. 2002; 48: 850–8. [PUBMED], [INFOTRIEVE]
- Schuck O, Gottfriedova H, Maly J, Jabor A, Stollova M, Bruzkova I, Skibova J, Ryska M, Spicak J, Trunecka P, Novakova J. Glomerular filtration rate assessment in individuals after orthotopic liver transplantation based on serum cystatin C levels. Liver Transpl. 2002; 8: 594–9. [PUBMED], [INFOTRIEVE]
- Berenguer-Pina J J, Noguera J, Canizares F, Hernandez-Bernal C, Velasco-Conesa E, Lozano-Postigo C, Patino A, Cabezuelo J, Acosta F, Martinez-Hernandez P, Ramirez P, Parrilla P. Cystatin C: A marker of glomerular filtration rate in liver transplantation. Transplant Proc. 2002; 34: 268–9. [PUBMED], [INFOTRIEVE]
- Leung N. A tale of two markers. Liver Transpl. 2002; 8: 600–2. [PUBMED], [INFOTRIEVE]
- Gerbes A L, Gulberg V, Bilzer M, Vogeser M. Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver. Gut. 2002; 50: 106–10. [PUBMED], [INFOTRIEVE]
- Randers E, Ivarsen P, Erlandsen E J, Hansen E F, Aagaard N K, Bendtsen F, Vilstrup H. Plasma cystatin C as a marker of renal function in patients with liver cirrhosis. Scand J Clin Lab Invest. 2002; 62: 129–34. [PUBMED], [INFOTRIEVE]
- Takeuchi M, Fukuda Y, Nakano I, Katano Y, Hayakawa T. Elevation of serum cystatin C concentrations in patients with chronic liver disease. Eur J Gastroenterol Hepatol. 2000; 13: 951–5
- Azuma K K, Balkovetz D F, Magyar C E, Lescale-Matys L, Zhang Y, Chambrey R, Warnock D G, McDonough A A. Renal Na+/H+ exchanger isoforms and their regulation by thyroid hormone. Am J Physiol. 1996; 270: c585–c592. [PUBMED], [INFOTRIEVE]
- Kreisman S H, Hennessey J V. Consistent reversible elevation of serum creatinine levels in severe hypothyroidism. Arch Intern Med. 1999; 159: 79–82. [PUBMED], [INFOTRIEVE]
- Ford H C, Lim W C, Chisnall W N, Pearce J M. Renal function and electrolyte levels in hyperthyroidism: Urinary protein excretion and the plasma concentration of urea, creatinine, uric acid, hydrogen ion and electrolytes. Clin Endocrinol (Oxf). 1989; 30: 293–301
- Jayagopal V, Keevil B G, Atkin S L, Jennings P E, Kilpatrick E S. Paradoxical changes in cystatin C and serum creatinine in patients with hypo- and hyperthyroidism. Clin Chem. 2003; 49: 680–1. [PUBMED], [INFOTRIEVE]
- Fricker M, Wiesli P, Brandle M, Schwegler B, Schmid C. Impact of thyroid dysfunction on serum cystatin C. Kidney Int. 2003; 63: 1944–7. [PUBMED], [INFOTRIEVE]
- Wiesli P, Schwegler B, Spinas G A, Schmid C. Serum cystatin C is sensitive to small changes in thyroid function. Clin Chim Acta. 2003; 338: 87–90. [PUBMED], [INFOTRIEVE]
- den, Hollander J G, Wulkan R W, Mantel M J, Berghout A. Is cystatin C a marker of glomerular filtration rate in thyroid dysfunction?. Clin Chem. 2003; 49: 1558–9. [PUBMED], [INFOTRIEVE]
- Schmitt R, Bachmann S. Impact of thyroid dysfunction on serum cystatin C. Kidney Int. 2003; 64: 1139–40. [PUBMED], [INFOTRIEVE]
- Clinical Guideline, Part 1. Screening for thyroid disease, American College of Physicians. Ann Intern Med. 1998; 129: 141–3
- Dunlop W. Serial changes in renal haemodynamics during normal human pregnancy. Br J Obstet Gynaecol. 1981; 88: 1–9. [PUBMED], [INFOTRIEVE]
- Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000; 183: s1–s22
- Krutzen E, Olofsson P, Back S E, Nilsson-Ehle P. Glomerular filtration rate in pregnancy: A study in normal subjects and in patients with hypertension, preeclampsia and diabetes. Scand J Clin Lab Invest. 1992; 52: 387–92. [PUBMED], [INFOTRIEVE]
- Strevens H, Wide-Swensson D, Grubb A. Serum cystatin C is a better marker for preeclampsia than serum creatinine or serum urate. Scand J Clin Lab Invest. 2001; 61: 575–80. [PUBMED], [INFOTRIEVE]
- Strevens H, Wide-Swensson D, Torffvit O, Grubb A. Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy. Scand J Clin Lab Invest. 2002; 62: 141–7. [PUBMED], [INFOTRIEVE]
- Strevens H, Wide-Swensson D, Grubb A, Hansen A, Horn T, Ingemarsson I, Larsen S, Nyengaard J R, Torffvit O, Willner J, Olsen S. Serum cystatin C reflects glomerular endotheliosis in normal, hypertensive and pre-eclamptic pregnancies. Br J Obstetr Gynecol. 2003; 110: 825–30
- Roderick P. Epidemiology of end-stage renal disease. Clin Med. 2002; 2: 200–4. [PUBMED], [INFOTRIEVE]
- Walser M. Assessing renal function from creatinine measurements in adults with chronic renal failure. Am J Kidney Dis. 1998; 32: 1–22
- Mitch W E, Collier V U, Walser M. Creatinine metabolism in chronic renal failure. Clin Sci. 1980; 58: 327–35. [PUBMED], [INFOTRIEVE]
- Rodrigo E, de, Francisco A L, Escallada R, Ruiz J C, Fresnedo G F, Pinera C, Arias M. Measurement of renal function in pre-ESRD patients. Kidney Int. 2002; 61(Suppl 80)s11–s17
- Fishbane S, Goldman R. Quality outcomes and obstacles to their achievement in end-stage renal disease. Semin Dial. 2002; 15: 30–4. [PUBMED], [INFOTRIEVE]
- Bonomini V, Feletti C, Scolari M P, Stefoni S. Benefits of early initiation of dialysis. Kidney Int. 1985; 28(Suppl 17)s57–s59
- Lindgren S C, Laurell C B, Sterner G N. Plasma protein homeostasis in chronic hemodialysis patients. Scand J Urol Nephrol. 1992; 26: 279–82. [PUBMED], [INFOTRIEVE]
- Bökenkamp A, Ciarimboli G, Dieterich C. Cystatin C in a rat model of end-stage renal failure. Ren Fail. 2001; 23: 431–8
- Kabanda A, Jadoul M, Pochet J M, Lauwerys R, van, Ypersele, de, Strihou C, Bernard A. Determinants of the serum concentrations of low molecular weight proteins in patients on maintenance hemodialysis. Kidney Int. 1994; 45: 1689–96. [PUBMED], [INFOTRIEVE]
- Kabanda A, Goffin E, Bernard A, Lauwerys R, van, Ypersele de Strihou C. Factors influencing serum levels and peritoneal clearances of low molecular weight proteins in continuous ambulatory peritoneal dialysis. Kidney Int. 1995; 48: 1946–52. [PUBMED], [INFOTRIEVE]
- Montini G, Amici G, Milan S, Mussap M, Naturale M, Ratsch I M, Ammenti A, Sorino P, Verrina E, Andreetta B, Zacchello G. Middle molecule and small protein removal in children on peritoneal dialysis. Kidney Int. 2002; 61: 1153–9. [PUBMED], [INFOTRIEVE]
- Laux C, Weiss B, Bonzel K E. Middle molecules in peritoneal equilibration test as a marker of peritoneal stress in children on continuous peritoneal dialysis. Adv Perit Dial. 1999; 15: 283–6. [PUBMED], [INFOTRIEVE]
- Randers E, Erlandsen E J. Serum cystatin C as an endogenous marker of the renal function—a review. Clin Chem Lab Med. 1999; 37: 389–95. [PUBMED], [INFOTRIEVE]
- Fanos V, Mussap M, Plebani M, Cataldi L. Cystatin C in paediatric nephrology. Present situation and prospects. Minerva Pediatr. 1999; 51: 167–77. [PUBMED], [INFOTRIEVE]
- Page M K, Bukki J, Luppa P, Neumeier D. Clinical value of cystatin C determination. Clin Chim Acta. 2000; 297: 67–72. [PUBMED], [INFOTRIEVE]
- Grubb A O. Cystatin C—properties and use as diagnostic marker. Adv Clin Chem. 2000; 35: 63–99. [PUBMED], [INFOTRIEVE]
- Reed C H. Diagnostic applications of cystatin C. Br J Biomed Sci. 2000; 57: 323–9. [PUBMED], [INFOTRIEVE]
- Dworkin L D. Serum cystatin C as a marker of glomerular filtration rate. Curr Opin Nephrol Hypertens. 2001; 10: 551–3. [PUBMED], [INFOTRIEVE]
- Tomino Y. Serum cystatin C. Contrib Nephrol. 2001; 134: 82–4. [PUBMED], [INFOTRIEVE]
- Lupovitch A. More accurate alternatives to serum creatinine for evaluating glomerular filtration rate. Clin Chem. 2002; 48: 2297–8. [PUBMED], [INFOTRIEVE]
- Newman D J. Cystatin C: What more do we need to know?. Nephron Clin Pract. 2003; 93: c122–c123. [PUBMED], [INFOTRIEVE]
- Fanos V, Mussap M, Khoory B J, Vecchini S, Plebani M, Benini D. Renal tolerability of teicoplanin in a case of neonatal overdose. J Chemother. 1998; 10: 381–4. [PUBMED], [INFOTRIEVE]
- Revesz T, Ghiso J, Lashley T, Plant G, Rostagno A, Frangione B, Holton J L. Cerebral amyloid angiopathies: A pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol. 2003; 62: 885–98. [PUBMED], [INFOTRIEVE]
- Cohen D H, Feiner H, Jensson O, Frangione B. Amyloid fibril in hereditary cerebral hemorrhage with amyloidosis (HCHWA) is related to the gastroentero-pancreatic neuroendocrine protein, gamma trace. J Exp Med. 1983; 158: 623–8. [PUBMED], [INFOTRIEVE]
- Walker L C, Durham R A. Cerebrovascular amyloidosis: Experimental analysis in vitro and in vivo. Histol Histopathol. 1999; 14: 827–37. [PUBMED], [INFOTRIEVE]
- Levy E, Sastre M, Kumar A, Gallo G, Piccardo P, Ghetti B, Tagliavini F. Codeposition of cystatin C with amyloid-β protein in the brain of Alzheimer disease patients. J Neuropathol Exp Neurol. 2001; 60: 94–104. [PUBMED], [INFOTRIEVE]
- Izumihara A, Ishihara T, Hoshii Y, Ito H. Cerebral amyloid angiopathy associated with hemorrhage: Immunohistochemical study of 41 biopsy cases. Neurol Med Chir (Tokyo). 2001; 41: 471–7
- Maruyama K, Ikeda S, Ishihara T, Allsop D, Yanagisawa N. Immunohistochemical characterization of cerebrovascular amyloid in 46 autopsied cases using antibodies to beta protein and cystatin C. Stroke. 1990; 21: 397–403. [PUBMED], [INFOTRIEVE]
- Glenner G G, Henry J H, Fujihara S. Congophilic angiopathy in the pathogenesis of Alzheimer's degeneration. Ann Pathol. 1981; 1: 120–9. [PUBMED], [INFOTRIEVE]
- Frangione B, Revesz T, Vidal R, Holton J, Lashley T, Houlden H, Wood N, Rostagno A, Plant G, Ghiso J. Familial cerebral amyloid angiopathy related to stroke and dementia. Amyloid. 2001; 8(Suppl 1)36–42. [PUBMED], [INFOTRIEVE]
- Crawford F C, Freeman M J, Schinka J A, Abdullah L I, Gold M, Hartman R, Krivian K, Morris M D, Richards D, Duara R, Anand R, Mullan M J. A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease. Neurology. 2000; 55: 763–8. [PUBMED], [INFOTRIEVE]
- Benussi L, Ghidoni R, Steinhoff T, Alberici A, Villa A, Mazzoli F, Nicosia F, Barbiero L, Broglio L, Feudatari E, Signorini S, Finckh U, Nitsch R M, Binetti G. Alzheimer disease-associated cystatin C variant undergoes impaired secretion. Neurobiol Dis. 2003; 13: 15–21. [PUBMED], [INFOTRIEVE]
- Luyendijk W, Schoen J. Intracerebral haematomas. A clinical study of 40 surgical cases. Psychiatr Neurol Neurochir. 1964; 67: 445–68. [PUBMED], [INFOTRIEVE]
- Yamada M. Cerebral amyloid angiopathy: An overview. Neuropathology. 2000; 20: 8–22. [PUBMED], [INFOTRIEVE]
- Levy E, Carman M D, Fernandez-Madrid I J, Power M D, Lieberburg I, van, Duinen S G, Bots G TAM, Luyendijk W, Frangione B. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science. 1990; 248: 1124–26. [PUBMED], [INFOTRIEVE]
- Jensson O, Palsdottir A, Thorsteinsson L, Arnason A. The saga of cystatin C gene mutation causing amyloid angiopathy and brain hemorrhage—clinical genetics in Iceland. Clin Genet. 1989; 36: 368–77. [PUBMED], [INFOTRIEVE]
- Ólafsson I, Grubb A. Hereditary cystatin C amyloid angiopathy. Amyloid. 2000; 7: 70–9
- Askanas V, Engel W K. Inclusion-body myositis and myopathies: Different etiologies, possibly similar pathogenetic mechanisms. Curr Opin Neurol. 2002; 15: 525–31. [PUBMED], [INFOTRIEVE]
- Vattemi G, Engel W K, McFerrin J, Askanas V. Cystatin C colocalizes with amyloid-beta and coimmunoprecipitates with amyloid-beta precursor protein in sporadic inclusion-body myositis muscles. J Neurochem. 2003; 85: 1539–46. [PUBMED], [INFOTRIEVE]
- Ghiso J, Pons-Estel B, Frangione B. Hereditary cerebral amyloid angiopathy: The amyloid fibrils contain a protein which is a variant of cystatin C, an inhibitor of lysosomal cysteine proteases. Biochem Biophys Res Commun. 1986; 136: 548–54. [PUBMED], [INFOTRIEVE]
- Gerhartz B, Abrahamson M. Physico-chemical properties of the N-terminally truncated L68Q cystatin C found in amyloid deposits of brain haemorrhage patients. Biol Chem. 2002; 383: 301–5. [PUBMED], [INFOTRIEVE]
- Gudmundsson G, Hallgrimsson J, Jonasson T A, Bjarnason O. Hereditary cerebral hemorrhage with amyloidosis. Brain. 1972; 95: 387–404. [PUBMED], [INFOTRIEVE]
- Árnason A. Apoplexie und ihre Vererbung. Acta Psychiatr Neur. 1935, Suppl VII: 1–180
- Löfberg H, Grubb A O, Nilsson E K, Jensson O, Gudmundsson G, Blondal H, Arnason A, Thorsteinsson L. Immunohistochemical characterization of the amyloid deposits and quantitation of pertinent cerebrospinal fluid proteins in hereditary cerebral hemorrhage with amyloidosis. Stroke. 1987; 18: 431–40
- Grubb A, Jensson O, Gudmundsson G, Arnason A, Lofberg H, Malm J. Abnormal metabolism of gamma-trace alkaline microprotein. The basic defect in hereditary cerebral hemorrhage with amyloidosis. N Engl J Med. 1984; 311: 1547–9. [PUBMED], [INFOTRIEVE]
- Palsdottir A, Abrahamson M, Thorsteinsson L, Arnason A, Ólafsson I, Grubb A, Jensson O. Mutation in cystatin C gene causes hereditary brain haemorrhage. Lancet. 1988; 2: 603–4. [PUBMED], [INFOTRIEVE]
- Benedikz E, Blondal H, Gudmundsson G. Skin deposits in hereditary cystatin C amyloidosis. Virchows Arch A Pathol Anat Histopathol. 1990; 417: 325–31. [PUBMED], [INFOTRIEVE]
- Jensson O, Gudmundsson G, Arnason A, Blondal H, Petursdottir I, Thorsteinsson L, Grubb A, Lofberg H, Cohen D, Frangione B. Hereditary cystatin C (gamma-trace) amyloid angiopathy of the CNS causing cerebral hemorrhage. Acta Neurol Scand. 1987; 76: 102–14. [PUBMED], [INFOTRIEVE]
- Wei L, Berman Y, Castano E M, Cadene M, Beavis R C, Devi L, Levy E. Instability of the amyloidogenic cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type. J Biol Chem. 1998; 273: 11806–14. [PUBMED], [INFOTRIEVE]
- Fujihara S, Shimode K, Kobayashi S, Tsunematsu T, Kagawa R. Possibly “familial” cerebral amyloid angiopathy in Japan: Immunohistochemical identification of gamma-trace. Rinsho Shinkeigaku. 1988; 28: 453–8. [PUBMED], [INFOTRIEVE]
- Sloane B F. Suicidal tumor proteases. Nat Biotech. 1996; 14: 826–7
- Newman D. More on cystatin C. Clin Chem. 1999; 45: 718–9. [PUBMED], [INFOTRIEVE]
- Kos J, Werle B, Lah T, Brunner N. Cysteine proteinases and their inhibitors in extracellular fluids: Markers for diagnosis and prognosis in cancer. Int J Biol Markers. 2000; 15: 84–9. [PUBMED], [INFOTRIEVE]
- Zore I, Krasovec M, Cimerman N, Kuhelj R, Werle B, Nielsen H J, Brunner N, Kos J. Cathepsin B/cystatin C complex levels in sera from patients with lung and colorectal cancer. Biol Chem. 2001; 382: 805–10. [PUBMED], [INFOTRIEVE]
- Iacobuzio-Donahue C A, Shuja S, Cai J, Peng P, Murnane M J. Elevation in cathepsin B protein and enzyme activity occur independently of glycosylation during colorectal tumor progression. J Biol Chem. 1997; 272: 29190–9. [PUBMED], [INFOTRIEVE]
- Siewinski M, Gutowicz J, Kielan W, Bolanowski M. Cysteine peptidase inhibitors and activator(s) in urine of patients with colorectal cancer. Oncology. 1994; 51: 446–9. [PUBMED], [INFOTRIEVE]
- Almeida P C, Nantes I L, Chagas J R, Rizzi C A, Falijoni-Alario A, Carmona E, Juliano L, Nader H B, Tersariol L S. Cathepsin B activity regulation. Heparin-like glycosaminogylcans protect human cathepsin B from alkaline pH-induced inactivation. J Biol Chem. 2001; 276: 944–51. [PUBMED], [INFOTRIEVE]
- Yoshimura K, Tsuchida T, Kawamoto K. Expression of cathepsin B and cystatin C in the human adenohypophysis and in pituitary adenomas. Oncol Rep. 2000; 7: 27–31. [PUBMED], [INFOTRIEVE]
- Sloane B F. Cathepsin B and cystatins: Evidence for a role in cancer progression. Semin Cancer Biol. 1990; 1: 137–52. [PUBMED], [INFOTRIEVE]
- Huh C G, Hakansson K, Nathanson C M, Thorgeirsson U P, Jonsson N, Grubb A, Abrahamson M, Karlsson S. Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene. Mol Pathol. 1999; 52: 332–40. [PUBMED], [INFOTRIEVE]
- Konduri S D, Yanamandra N, Siddique K, Joseph A, Dinh D H, Olivero W C, Gujrati M, Kouraklis G, Swaroop A, Kyritsis A P, Rao J S. Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene. 2002; 21: 8705–12. [PUBMED], [INFOTRIEVE]
- Foekens J A, Kos J, Peters H A, Krasovec M, Look M P, Cimerman N, Meijer-van Gelder ME, Henzen-Logmans S C, van, Putten W L, Klijn J G. Prognostic significance of cathepsins B and L in primary human breast cancer. J Clin Oncol. 1998; 16: 1013–21. [PUBMED], [INFOTRIEVE]
- Lah T T, Cercek M, Blejec A, Kos J, Gorodetsky E, Somers R, Daskal I. Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: Comparison with cathepsin D, cathepsin L, and other clinical indicators. Clin Cancer Res. 2000; 6: 578–84. [PUBMED], [INFOTRIEVE]
- Werle B, Lotterle H, Schanzenbacher U, Lah T T, Kalman E, Kayser K, Bulzebruck H, Schirren J, Krasovec M, Kos J, Spiess E. Immunochemical analysis of cathepsin B in lung tumours: An independent prognostic factor for squamous cell carcinoma patients. Br J Cancer. 1999; 81: 510–9. [PUBMED], [INFOTRIEVE]
- Usova T A, Poteryaeva O N, Zhanayeva S Y, Yarygina E S, Korolenko T A. Cystatin C and cysteine proteinases during the development and therapy of Lewis lung adenocarcinoma in mice. Bull Exp Biol Med. 2003; 135: 81–4. [PUBMED], [INFOTRIEVE]
- Strojnik T, Kos J, Zidanik B, Golouh R, Lah T. Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors. Clin Cancer Res. 1999; 5: 559–67. [PUBMED], [INFOTRIEVE]
- Hirai K, Yokoyama M, Asano G, Tanaka S. Expression of cathepsin B and cystatin C in human colorectal cancer. Hum Pathol. 1999; 30: 680–6. [PUBMED], [INFOTRIEVE]
- Strojan P, Budihna M, Smid L, Svetic B, Vrhovec I, Kos J, Skrk J. Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res. 2000; 6: 1052–62. [PUBMED], [INFOTRIEVE]
- Kos J, Stabuc B, Schweiger A, Krasovec M, Cimerman N, Kopitar-Jerala N, Vrhovec I. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. Clin Cancer Res. 1997; 3: 1815–22. [PUBMED], [INFOTRIEVE]
- Kos J, Stabuc B, Cimerman N, Brunner N. Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression. Clin Chem. 1998; 44: 2556–7. [PUBMED], [INFOTRIEVE]
- Lah T T, Kokalj-Kunovar M, Kastelic L, Babnik J, Stolfa A, Rainer S, Turk V.. Cystatins and stefins in ascites fluid from ovarian carcinoma. Cancer Lett. 1992; 61: 243–53. [PUBMED], [INFOTRIEVE]
- Kos J, Nielsen H J, Krasovec M, Christensen I J, Cimerman N, Stephens R W, Brunner N. Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer. Clin Cancer Res. 1998; 4: 1511–6. [PUBMED], [INFOTRIEVE]
- Kos J, Krasovec M, Cimerman N, Nielsen H J, Christensen I J, Brunner N. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: Relation to prognosis. Clin Cancer Res. 2000; 6: 505–11. [PUBMED], [INFOTRIEVE]
- Yano M, Hirai K, Naito Z, Yokoyama M, Ishiwata T, Shiraki Y, Inokuchi M, Asano G. Expression of cathepsin B and cystatin C in human breast cancer. Surg Today. 2001; 31: 385–9. [PUBMED], [INFOTRIEVE]
- Gaumann A, Hansen T, Kohler H H, Kommoss F, Mann W, Maurer J, Kirkpatrick C J, Kriegsmann J. The expression of cathepsins in osteoclast-like giant cells of an anaplastic thyroid carcinoma with tracheal perforation. Pathol Res Pract. 2001; 197: 257–62. [PUBMED], [INFOTRIEVE]
- Keppler D, Waridel P, Abrahamson M, Bachmann D, Berdoz J, Sordat B. Latency of cathepsin B secreted by human colon carcinoma cells is not linked to secretion of cystatin C and is relieved by neutrophil elastase. Biochim Biophys Acta. 1994, 1226; 117–25
- Sexton P S, Cox J L. Inhibition of motility and invasion of B16 melanoma by the overexpression of cystatin C. Melanoma Res. 1997; 7: 97–101. [PUBMED], [INFOTRIEVE]
- Cox J L, Sexton P S, Green T J, Darmani N A. Inhibition of B16 melanoma metastasis by overexpression of the cysteine proteinase inhibitor cystatin C. Melanoma Res. 1999; 9: 369–74. [PUBMED], [INFOTRIEVE]
- Krepela E, Prochazka J, Karova B, Cermak J, Roubkova H. Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer. Neoplasma. 1998; 45: 318–3. [PUBMED], [INFOTRIEVE]
- Ebert E, Werle B, Julke B, Kopitar-Jerala N, Kos J, Lah T, Abrahamson M, Spiess E, Ebert W. Expression of cysteine protease inhibitors stefin A, stefin B, and cystatin C in human lung tumor tissue. Adv Exp Med Biol. 1997; 421: 259–65. [PUBMED], [INFOTRIEVE]
- Finney H, Williams A H, Price C P. Serum cystatin C in patients with myeloma. Clin Chim Acta. 2001; 309: 1–6. [PUBMED], [INFOTRIEVE]
- Mojiminiyi O A, Marouf R, Abdella N, Kortom M, Abdul-Razzak R. Serum concentration of cystatin C is not affected by cellular proliferation in patients with proliferative haematological disorders. Ann Clin Biochem. 2002; 39: 308–10. [PUBMED], [INFOTRIEVE]
- Stabuc B, Vrhovec L, Stabuc-Silih M, Cizej T E. Improved prediction of decreased creatinine clearance by serum cystatin C: Use in cancer patients before and during chemotherapy. Clin Chem. 2000; 46: 193–7. [PUBMED], [INFOTRIEVE]
- Al-Tonbary Y A, Hammad A M, Zaghloul H M, EI-Sayed H E, Abu-Hashem E. Pretreatment cystatin C in children with malignancy: Can it predict chemotherapy-induced glomerular filtration rate reduction during the induction phase?. J Pediatr Hetamol Oncol. 2004 Jun; 26(6)336–41
- Manjunath G, Sarnak M J, Levey A S. Estimating the glomerular filtration rate. Dos and don'ts for assessing kidney function. Postgrad Med. 2001; 110: 55–62. [PUBMED], [INFOTRIEVE]